Jump to content

SARS-CoV-2 Omicron variant

From Wikipedia, the free encyclopedia

SARS-CoV-2 Variant
Omicron
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
General details
WHO DesignationOmicron
LineageB.1.1.529
First detectedSouth Africa
Date reported24 November 2021; 2 years ago (2021-11-24)
StatusVariant of concern
Symptoms
Asymptomatic infection,[1] body ache,[1] cough,[1] fainting,[2] fatigue,[3] fever, headache,[4] loss of smell or taste,[5][6] — less common nasal congestion or running nose[4] night sweats,[7] — unique Omicron symptom, upper respiratory tract infection[8] skin rash,[9] sneezing,[4] sore throat[2]
Major variants

Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021.[10][11] It was first detected in Botswana and has spread to become the predominant variant in circulation around the world.[12] Following the original B.1.1.529 variant, several subvariants of Omicron have emerged including: BA.1, BA.2, BA.3, BA.4, and BA.5.[13] Since October 2022, two subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged.

Three doses of a COVID-19 vaccine provide protection against severe disease and hospitalisation caused by Omicron and its subvariants.[14][15][16][17] For three-dose vaccinated individuals, the BA.4 and BA.5 variants are more infectious than previous subvariants but there is no evidence of greater sickness or severity.[13][18][19]

Classification

[edit]
Omicron variant and other major or previous variants of concern of SARS-CoV-2 depicted in a tree scaled radially by genetic distance, derived from Nextstrain on 1 December 2021

On 26 November 2021, the WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution declared PANGO lineage B.1.1.529 a variant of concern and designated it with the Greek letter omicron.[10] The WHO skipped the preceding letters nu and xi in the Greek alphabet to avoid confusion with the similarities of the English word "new" and the Chinese surname Xi.[20]

The name of the variant has occasionally been mistaken as "Omnicron" among some English speakers, due to a lack of familiarity with the Greek alphabet, and the relative frequency of the Latin prefix "omni" in other common speech.[21][22]

The GISAID project has assigned it the clade identifier GR/484A,[23] and the Nextstrain project has assigned it the clade identifiers 21K and 21L, both belonging to a larger Omicron group 21M.[24]

History

[edit]

Omicron was first detected on 22 November 2021 in laboratories in Botswana and South Africa based on samples collected on 11–16 November,[25] with the first known samples collected in Johannesburg, South Africa on 8 November 2021.[26] The first known cases outside of South Africa were two people who travelled on 11 November: one who flew from South Africa to Hong Kong via Qatar, and another who travelled from Egypt to Belgium via Turkey.[27][28] On 26 November 2021, WHO designated B.1.1.529 as a variant of concern and named it "Omicron", after the fifteenth letter in the Greek alphabet.[10] As of 6 January 2022, the variant had been confirmed in 149 countries.[29]

Origin hypotheses

[edit]

Omicron did not evolve from any other variant, but instead diverged on a distinct track, perhaps in mid-2020.[29][30] Competing hypotheses are being examined.

One origin hypothesis is that various mutations in the Omicron variant, comprising a 9-nucleotide sequence, may have been acquired from another coronavirus (known as HCoV-229E), responsible for the common cold.[31] This is not entirely unexpected — at times, viruses within the body acquire and swap segments of genetic material from each other, and this is one common means of mutation.[31]

A link with HIV infection may explain a large number of mutations in the sequence of the Omicron variant.[32] Indeed, in order to be affected by such a high number of mutations, the virus must have been able to evolve a long time without killing its host, which can occur in people with a weakened immune system who receive enough medical care to survive.[32][33] This is the case in HIV patients in South Africa, who represent about 14% of the population (as of 2017).[34] HIV prevention could be key to reducing the risk of uncontrolled HIV driving the emergence of SARS-CoV-2 variants.[32]

One hypothesis to explain the novel mutations is that SARS-CoV-2 was transmitted from humans to mice and mutated in a population of mice sometime between mid-2020 and late 2021 before reinfecting humans.[30]

On 1 December 2022, a team of researchers from the Charité (Berlin) published a now-retracted study in Science (journal) that claimed that "data revealed genetically diverse Omicron ancestors already existed across Africa by August 2021".[35] After a re-analysis because of doubts,[36] the team retracted the article on 20 December 2022 due to contamination of the samples.[37][38]

Spread

[edit]

On 24 November 2021, the variant was first reported to the WHO from South Africa based on samples that had been collected from 14 to 16 November.[25] South African scientists were first alerted by samples from the very beginning of November where the PCR tests had S gene target failure (occurs in a few variants, but not in Delta which dominated in the country in October) and by a sudden increase of COVID-19 cases in Gauteng; sequencing revealed that more than 70 percent of samples collected in the province between 14 and 23 November were a new variant.[39]

The first confirmed specimens of Omicron were collected on 8 November 2021 in South Africa and on 9 November in Botswana.[40] Likely Omicron (SGTF) samples had occurred on 4 November 2021 in Pretoria, South Africa.[citation needed]

When WHO was alerted on 24 November, Hong Kong was the only place outside Africa that had confirmed a case of Omicron; one person who traveled from South Africa on 11 November, and another traveler who was cross-infected by this case while staying in the same quarantine hotel.[27]

On 25 November, one confirmed case was identified in Israel from a traveler returning from Malawi,[41] along with two who returned from South Africa and one from Madagascar.[42] All four initial cases reported from Botswana occurred among fully vaccinated individuals.[43]

On 26 November, Belgium confirmed its first case; an unvaccinated person who had travelled from Egypt via Turkey on 11 November.[28] All three initial confirmed and suspected cases reported from Israel occurred among fully vaccinated individuals,[41] as did a single suspected case in Germany.[44]

On 27 November, two cases were detected in the United Kingdom, another two in Munich, Germany and one in Milan, Italy.[45]

On 28 November, 13 cases were confirmed in the Netherlands among the 624 airline passengers who arrived from South Africa on 26 November.[46] Confirmation of a further 5 cases among these passengers followed later.[47] Entry into the Netherlands generally required having been vaccinated or PCR-tested, or having recovered. The passengers of these two flights had been tested upon arrival because of the newly imposed restrictions (which were set in place during their flight), after which 61 tested positive for SARS-CoV-2.[48] A further two cases were detected in Australia. Both people landed in Sydney the previous day, and travelled from southern Africa to Sydney Airport via Doha Airport. The two people, who were fully vaccinated, entered isolation; 12 other travellers from southern Africa also entered quarantine for fourteen days, while about 260 other passengers and crew on the flight were directed to isolate.[49] Two travellers from South Africa who landed in Denmark tested positive for COVID-19; it was confirmed on 28 November that both carried the Omicron variant.[50][51] On the same day, Austria also confirmed its first Omicron case.[52] A detected Omicron case was reported in the Czech Republic, from a traveler who spent time in Namibia.[53] Canada also reported its first Omicron cases, with two from travelers from Nigeria, therefore becoming the first North American country to report an Omicron case.[54]

On 29 November, a positive case was recorded in Darwin, Australia. The person arrived in Darwin on a repatriation flight from Johannesburg, South Africa on 25 November, and was taken to a quarantine facility, where the positive test was recorded.[55] Two more people who travelled to Sydney from southern Africa via Singapore tested positive.[56] Portugal reported 13 Omicron cases, all of them members of a soccer club.[57] Sweden also confirmed their first case on 29 November,[58] as did Spain, when a traveler came from South Africa.[59]

On 30 November, the Netherlands reported that Omicron cases had been detected in two samples dating back as early as 19 November.[60] A positive case was recorded in Sydney from a traveller who had visited southern Africa before travel restrictions were imposed, and was subsequently active in the community.[61] Japan also confirmed its first case.[62] Two Israeli doctors tested positive and entered isolation. Both of them had received three shots of the Pfizer vaccine prior to testing positive.[63] In Brazil, three cases of the Omicron variant were confirmed in São Paulo.[64] Another five are under suspicion.[65][66] A person in Leipzig, Germany with no travel history nor contact with travellers tested positive for Omicron.[67]

On 1 December, the Omicron variant was detected in three samples in Nigeria that had been collected from travelers from South Africa within the last week.[68][69] On the same day, public health authorities in the United States announced the country's first confirmed Omicron case. A resident of San Francisco who had been vaccinated returned from South Africa on 22 November, began showing mild symptoms on 25 November[70] and was confirmed to have a mild case of COVID-19 on 29 November.[71] Ireland and South Korea also reported their first cases.[72] South Korea reported its cases from five travelers arriving in South Korea from Nigeria.[73]

On 2 December, Dutch health authorities confirmed that all 14 passengers with confirmed Omicron infection on 26 November had been previously vaccinated.[74] The same day, the Norwegian Institute of Public Health confirmed that 50 attendees of a company Christmas party held at a restaurant in Norway's capital, Oslo, were infected with the Omicron variant.[75] France has confirmed only 25 cases of the new Omicron variant but officials say the number could jump significantly in the coming weeks.[76]

By 6 December, Malaysia confirmed its first case of the variant. The case was a South African student entering to study at a private university.[77] In Namibia, 18 cases out of 19 positive COVID-19 samples that had been collected between 11 and 26 November were found to be Omicron, indicating a high level of prevalence in the country.[78] Fiji also confirmed two positive cases of the variant. They travelled from Nigeria arriving in Fiji on November 25.[79]

On 9 December, Richard Mihigo, coordinator of the World Health Organisation's Immunisation and Vaccine Development Programme for Africa, announced that Africa accounted for 46% of reported cases of the Omicron variant globally.[80]

On 13 December, the first death of a person with Omicron was reported in the UK.[81]

On 16 December, New Zealand confirmed its first case of the Omicron variant, an individual who had traveled from Germany via Dubai.[82]

The first death of a person with Omicron was reported in Germany on 23 December[83] and in Australia on 27 December.[84]

By Christmas 2021, the Omicron Strain became dominant in the US.[85]

On 3 January 2022, South Korea reported the first two deaths of people who tested positive post mortem for Omicron.[86]

In February 2022, Omicron accounted for 98% of publicly available genetic sequences worldwide.[87]

On 29 March 2022, Omicron subvariant BA.2 overtook BA.1 and became the dominant strain in the U.S.[88][89][90]

As of May 2022, BA.2.12.1 was spreading in the US and two new subvariants of Omicron named BA.4 and BA.5, first detected in January 2022, spread in South Africa. All 3 subvariants have spike protein mutations of L452 and elude immunity from prior BA1 infection.[91]

On 16 March 2023, without seeing a reduction in the threat to public health, the WHO stopped classifying Omicron as a variant of concern in order to maintain this classification only for new threats. Instead, the WHO classified its subvariants as variants of interest and under monitoring.[87]

Reactions

[edit]

Vaccine producers

[edit]

On 26 November 2021, BioNTech said it would know in two weeks whether the current vaccine is effective against the variant and that an updated vaccine could be shipped in 100 days if necessary. AstraZeneca, Moderna and Johnson & Johnson were also studying the variant's impact on the effectiveness of their vaccines.[92] On the same day, Novavax stated that it was developing an updated vaccine requiring two doses for the Omicron variant, which the company expected to be ready for testing and manufacturing within a few weeks.[93][94] On 29 November 2021, The Gamaleya Institute said that Sputnik Light should be effective against the variant, that it would begin adapting Sputnik V, and that a modified version could be ready for mass production in 45 days.[95] Sinovac said it could quickly mass-produce an inactivated vaccine against the variant and that it was monitoring studies and collecting samples of the variant to determine if a new vaccine is needed.[96]

On 7 December 2021, at a symposium in Brazil with its partner Instituto Butantan, Sinovac said it would update its vaccine to the new variant and make it available in three months.[97] On 2 December, the Finlay Institute was already developing a version of Soberana Plus against the variant.[98] Pfizer hoped to have a vaccine targeted to immunize against Omicron ready by March 2022.[99]

World Health Organization

[edit]

On 26 November 2021, the WHO asked nations to enhance surveillance and sequencing efforts, submit complete genome sequences and associated metadata to a publicly available database, such as GISAID, report initial cases/clusters associated with virus-of-concern infection to WHO through the IHR mechanism, where capacity exists and in coordination with the international community, perform field investigations and laboratory assessments to improve understanding of the potential impacts of the virus of concern on COVID-19 epidemiology, severity, and the effectiveness of public health and social measures, diagnostic methods, immune responses, antibody neutralization, or other relevant characteristics.[100] On 26 November 2021, WHO advised countries not to impose new restrictions on travel, instead recommending a "risk-based and scientific" approach to travel measures.[101] On the same day, the European Centre for Disease Prevention and Control (ECDC) reported modeling indicating that strict travel restrictions would delay the variant's impact on European countries by two weeks, possibly allowing countries to prepare for it.[102] As with other variants, the WHO recommended that people continue to keep enclosed spaces well ventilated, avoid crowding and close contact, wear well-fitting masks, clean hands frequently, and get vaccinated.[103][104] On 29 November 2021, the WHO said cases and infections were expected among those vaccinated, albeit in a small and predictable proportion.[105]

International response

[edit]

After the WHO announcement, on the same day, several countries announced travel bans from southern Africa in response to the identification of the variant, including the United States, which banned travel from eight African countries,[106] although as of 30 November 2021 it notably did not ban travel from any European countries, Israel, Canada, or Australia where cases were also detected at the time the bans were announced. Other countries that also implemented travel bans include Japan, Canada, the European Union, Israel, Australia, the United Kingdom, Singapore, Malaysia, Indonesia, Morocco, and New Zealand.[107][108]

On 26 November 2021 the Brazilian Health Regulatory Agency recommended flight restrictions regarding the new variant.[109] The state of New York declared a state of emergency ahead of a potential Omicron spike, although no cases had yet been detected in the state or the rest of the United States.[110] On 27 November 2021, Switzerland introduced obligatory tests and quarantine for all visitors arriving from countries where the variant was detected, which originally included Belgium and Israel.[111]

On 26 November 2021 South African Minister of Health Joe Phaahla defended his country's handling of the pandemic and said that travel bans went against the "norms and standards" of the World Health Organization.[112]

Some speculated that travel bans could have a significant impact on South Africa's economy by limiting tourism and could lead to other countries with economies that are reliant on tourism to hide the discovery of new variants of concern. Low vaccine coverage in less-developed nations could create opportunities for the emergence of new variants, and these nations also were struggling to gain intellectual property to develop and produce vaccines locally.[113] At the same time, inoculation had slowed in South Africa due to vaccine hesitancy and apathy, with a nationwide vaccination rate of only 35% as of 24 November 2021.[114]

On 29 November 2021, the WHO warned countries that the variant poses a very high global risk with severe consequences and that they should prepare by accelerating vaccination of high-priority groups and strengthening health systems. WHO director-general Tedros Adhanom described the global situation as dangerous and precarious and called for a new agreement on the handling of pandemics, as the current system disincentivizes countries from alerting others to threats that will inevitably land on their shores. CEPI CEO Richard Hatchett said that the variant fulfilled predictions that transmission of the virus in low-vaccination areas would accelerate its evolution.[105]

In preparation for the Omicron variant arriving in the United States, President Joe Biden stated that the variant is "cause for concern, not panic", reiterated that the government was prepared for the variant and would have it under control and that large-scale lockdowns, similar to the ones in 2020 near the beginning of the pandemic, were "off the table for now."[115]

In mid-December 2021, multiple Canadian provinces reinstated restrictions on gatherings and events such as sports tournaments, and tightened enforcement of proof of vaccination orders. British Columbia expressly prohibited any non-seated "organized New Year's Eve event",[116][117][118] while Quebec announced a partial lockdown on 20 December 2021, ordering the closure of all bars, casinos, gyms, schools, and theatres, as well as imposing restrictions on the capacity and operating hours of restaurants, and the prohibition of spectators at professional sporting events.[119]

On 18 December 2021, the Netherlands government announced a lockdown intended to prevent spread of the variant during the holiday period.[120]

In late December 2021, some countries shortened the typical six-month interval for a booster dose of the vaccine to prepare for a wave of Omicron, as two doses are not enough to stop the infection. UK, South Korea and Thailand reduced to three months; Belgium, four months; France, Singapore, Taiwan, Italy and Australia, five months. Finland reduced it to three months for risk groups. Other countries continued with a six-month booster schedule. While antibody levels begin to drop at four months, a longer interval usually allows time for the immune system's response to mature.[121]

Market reactions

[edit]

On 26 November 2021, worry about the potential economic impact of the Omicron variant led to a drop in global markets, including the worst drop of the Dow Jones Industrial Average in 2021, led by travel-related stocks. The price of Brent Crude and West Texas Intermediate oil fell 10% and 11.7%, respectively[122] Cryptocurrency markets were also routed.[123][124] and the South African rand also hit an all-time low for 2021, trading at over 16 rand to the dollar, losing 6% of its value in November.[125][126][127]

In early December 2021, Jerome Powell, the chairman of the Federal Reserve, testified before the U.S. Senate Committee on Banking that "The recent rise in COVID-19 cases and the emergence of the Omicron variant pose downside risks to employment and economic activity and increased uncertainty for inflation."[128]

Biology

[edit]
The genomic sequence of the Omicron variant is pictured above

Mutations

[edit]

As of June 2022, Omicron had about 50 mutations relative to the Wuhan-Hu-1 or B variant,[129][130] which is more than any previous SARS-CoV-2 variant. Thirty-two of these pertained to the spike protein, which most vaccines target to neutralise the virus.[131] As of December 2021, many mutations were novel and not found in previous variants.[40] As of April 2022 the variant was characterised by 30 amino acid changes, three small deletions, and one small insertion in the spike protein compared with the original virus, of which 15 are located in the receptor-binding domain (residues 319–541).[132] As of December 2022 the virus carried a number of changes and deletions in other genomic regions. For example, three mutations at the furin cleavage site, which facilitates its transmission.[133][134]

Spike protein with mutations highlighted, looking down onto the receptor-binding domain
Spike protein with mutations highlighted, looking at the side of the protein
Illustration of the locations of the Omicron mutations in the spike protein, top view (left) and side view (right), showing amino acid substitutions (yellow), deletions (red), and insertions (green). In this trimeric structure, two monomers (gray and light blue) have their receptor-binding domains in the "down" conformation while one (dark blue) is in the "up" or "open" conformation. Mutation data from WHO,[103] structure from PDB: 6VYB​.[135]
Mutation prevalence across Omicron lineages
Comparison of mutation prevalence for ORF1a, ORF1b, and S genes of Omicron lineages that are designated Variants of Concern. Characteristic mutations for a lineage are defined as nonsynonymous substitutions or deletions that occur in > 75% of sequences within that lineage.[136]

Subvariants

[edit]

Several subvariants of Omicron have been discovered and new ones continue to emerge.[12] There are 310 Pango lineages[clarification needed] currently associated with the Omicron variant.[137] The 'standard' sublineage is now referred to as BA.1 (or B.1.1.529.1), and the two other sublineages are known as BA.2 (or B.1.1.529.2) and BA.3 (or B.1.1.529.3).[138] In mid-2022, BA.4 (or B.1.1.529.4) and BA.5 (or B.1.1.529.5) were detected in several countries.[139] They share many mutations, but also significantly differ. In general, BA.1 and BA.2 share 32 mutations, but differ by 28.[140] BA.1 has itself been divided in two, the original BA.1 and BA.1.1 (or B.1.1.529.1.1) where the main difference is that the latter has a R346K mutation.[141]

Standard PCR and rapid tests continue to detect all Omicron subvariants as COVID-19, but further tests are necessary to distinguish the subvariants from each other and from other COVID-19 variants.[142]

Defining mutations in the
SARS-CoV-2 Omicron variant
Gene Amino acid
ORF1ab nsp3: K38R
nsp3: V1069I
nsp3: Δ1265
nsp3: L1266I
nsp3: A1892T
nsp4: T492I
nsp5: P132H
nsp6: Δ105-107
nsp6: A189V
nsp12: P323L
nsp14: I42V
Spike A67V
Δ69-70
T95I
G142D,
Δ143-145
Δ211
L212I
ins214EPE
G339D
S371L
S373P
S375F
K417N
N440K
G446S
S477N
T478K
E484A
Q493R
G496S
Q498R
N501Y
Y505H
T547K
D614G
H655Y
N679K
P681H
N764K
D796Y
N856K
Q954H
N969K
L981F
E T9I
M D3G
Q19E
A63T
N P13L
Δ31-33
R203K
G204R
Sources: UK Health Security Agency[143] CoVariants[24]

BA.2

[edit]

BA.2 was first detected in a sample from 15 November 2021.[144] A preprint released in February 2022 (published in May) suggested that BA.2 was more transmissible than BA.1 and may cause more severe disease.[145] This was later disproven by a study in late-October 2022, that found BA.2 actually caused less severe disease relative to BA.1 (which in turn, caused less severe disease compared to the delta variant).[146] Therapeutic monoclonal antibodies used to treat people infected with COVID-19 did not have much effect on BA.2, which was "almost completely resistant" to casirivimab and imdevimab, and 35 times more resistant to sotrovimab than the BA.1 subvariant.[citation needed]

Spread

[edit]

As of 17 January 2022, BA.2 had been detected in at least 40 countries and in all continents except Antarctica.[147] By 31 January, it had been detected in at least 57 countries.[148] In global samples collected from 4 February to 5 March and uploaded to GISAID, BA.2 accounted for c. 34%, compared to 41% for BA.1.1, 25% for BA.1 and less than 1% for BA.3.[149] In a review two weeks later, covering 16 February to 17 March, BA.2 had become the most frequent.[150][151] Based on GISAID uploads, BA.1 peaked in early January 2022, after which it was overtaken by both BA.1.1 and BA.2.[152] In North America, parts of Europe and parts of Asia, BA.1 was first outcompeted by BA.1.1. For example, in the United States, France and Japan, BA.1.1 became the dominant subvariant in January 2022.[153][154][155]

By late December 2021/early January 2022, BA.2 had become dominant in parts of India (already making up almost 80 percent in Kolkata in late December 2021[156]) and the Philippines, had become frequent in Scandinavia, South Africa and Singapore, and was showing signs of growth in Germany and the United Kingdom.[157][158][159][160] In Japan, which has quarantine and detailed screening of all international travellers, as of 24 January, the vast majority of BA.2 had been detected in people that had arrived from India or the Philippines with cases going back at least to 1 December 2021 (far fewer BA.1 or other variants were detected among arrivals from the two countries in that period), but small numbers had also been detected in people arriving from other countries.[161][162][163]

In Denmark, the first BA.2 was in a sample collected on 5 December 2021.[164] By week fifty (13–19 December) it had started to increase, with BA.2 being at around 2 percent of sequenced cases compared to 46 percent BA.1 (remaining Delta). The frequency of both Omicron subvariants continued to increase throughout the last half of December; and by the end of the year BA.2 had reached 20 percent and BA.1 peaked at 72 percent. In January 2022, BA.1 began decreasing, whereas BA.2 continued its increase. By the second week of 2022, the frequency of the two was almost equal, both being near 50 percent.[164] In the following week, BA.2 became clearly dominant in Denmark with 65 percent of new cases.[165] Trends from the other Scandinavian countries, India, South Africa and the United Kingdom also showed that BA.2 was increasing in proportion to BA.1.[166][167] In early February 2022, it had become the dominant subvariant in South Africa, in late February it had become dominant in Germany and in early March it had become dominant in the United Kingdom.[168][169][170] In early March, BA.1.1 was still heavily dominant in the United States (having overtaken BA.1 in January), but BA.2 was increasing in frequency, later becoming dominant in the US by 29 March.[153][171]

XE

[edit]

A new BA.1–BA.2 recombinant was isolated in the UK in January 2022, dubbed the "XE" recombinant. It was found by the WHO to be potentially 10% more transmissible than BA.2, making it about 43% to 76% to more transmissible than BA.1, and making the XE recombinant the most contagious variant identified at the time.[172]

BA.2.12

[edit]

There were two new BA.2 subvariants detected in the US state of New York, which are BA.2.12 (or B.1.1.529.2.12) and BA.2.12.1 (or B.1.1.529.2.12.1), both of which have a significant growth advantage of 23–27% over BA.2 and contributing to a rise in infections in central New York, centred on Syracuse and Lake Ontario, which later became dominant by 24 May 2022, in the US.[173]

BA.2.75 and BA.2.75.2

[edit]

The subvariant BA.2.75 (or B.1.1.529.2.75, nicknamed Centaurus by the media[174]), first detected in India in May 2022, was classified as variant under monitoring by the WHO.[175] Additional newer mutations in this line (like BA.2.75.2 aka B.1.1.529.2.75.2 or Chiron) may be capable of escaping neutralizing antibodies.[176]

XBB and XBB.1
[edit]

XBB, a recombinant of the BA.2.10.1.1 and BA.2.75.3.1.1.1 sublineages,[177] is an Omicron subvariant first detected in August 2022.[178]

On 20 October 2022, the chief scientist of the World Health Organization (WHO), Soumya Swaminathan, warned that the XBB subvariant of Omicron may cause infections in some countries while the severity of the new variants is not yet known.[179]

On 9 January 2023 the European CDC said there was suggestive evidence the XBB.1.5 variant had a growth advantage; after becoming dominant in the US, it might become dominant in Europe in the following months.[180] From preliminary evidence, they had assessed the XBB variants had no effect on disease severity and transmissibility.[181]

In early March 2023, XBB.1.16 first appeared in India and caused a surge of hospitalizations.[182] It was nicknamed Arcturus by T. Ryan Gregory.[182][183][184]

EG.5 and EG.5.1
[edit]

EG.5 (or XBB.1.9.2.5), nicknamed by some media "Eris",[185] is a descendant of XBB.1.9.2. The lineage was detected as early as February 2023.[186] On 6 August, the UK Health Security Agency reported the EG.5 strain was responsible for one in seven new cases in the UK during the third week of July.[187] It was identified as a "variant of interest" by the WHO on 9 August 2023. Its key difference from other strains is a "F456L amino acid mutation".[188]

HV.1

[edit]

HV.1 (or XBB.1.9.2.5.1.6.1) is a sublineage of XBB.1.9.2, of the Omicron family first detected in July 2023.

HV.1 overtook EG.5 as the dominant subvariant in the U.S. in October 2023.[189] In October experts stated that there was no evidence that HV.1 was more severe or transmissible than other Omicron subvariants.[190]

BA.2.86

[edit]

In mid-August 2023, the CDC and WHO announced they were monitoring another subvariant of Omicron, BA.2.86, a descendant of the BA.2 subvariant. The WHO has placed BA.2.86 as a VUM (variant under monitoring) as it is reported to have more than 30 mutations.[191] As of 18 August, cases had been reported from four countries: three in Denmark and a single each in Israel, the UK and the US. On the same date, UK healthcare authorities noted that its almost simultaneous appearance in several countries still operating detailed genomic surveillance indicated that it likely already was spreading more widely internationally.[192] The first case of BA.2.86 was collected on 24 July 2023 according to the WHO.

BA.3

[edit]

The third Omicron sublineage, BA.3, is very rare. It has the same S-gene target failure (SGTF) deletion (Δ69-70) as BA.1.[citation needed]

BA.4 and BA.5

[edit]

In April 2022, the WHO announced it was tracking the BA.4 and BA.5 subvariants with BA.4 having been detected in South Africa, Botswana, Denmark, Scotland and England.[193] Early indications from data collected in South Africa suggested BA.4 and BA.5 have a significant growth advantage over BA.2, which by 12 May earned the status Variant of Concern by the European Centre for Disease Prevention and Control, and, by 20 May, by the UK Health Security Agency.[194][195][196][197] BA.5 was dominant in Portugal by 25 May, accounting for two-thirds of all new cases there.[198] By 24 June, BA.4 and BA.5 together had become dominant variants in the UK and Germany.[199][200][201][202] These two subvariants became dominant in the United States by 28 June.[203][204] By late June, BA.5 became the dominant subvariant in France, with 59% of new cases linked to it.[205][206]

On 10 May 2022, a case of a new subvariant BA.5.2.1 was reported in California.[207] On 10 July, the city of Shanghai reported its first case of BA.5.2.1, in a man who had flown in from Uganda, sparking a new wave of testing.[208] On 22 July, the province of Ontario, Canada announced that subvariant BA.5.2.1 overtook BA.2.12.1 as the main variant in circulation in Ontario around 2 July.[209] Regeneron is reporting that BA.5.2.1 is the main variant in Australia, Belgium, Brunei, Greece and Iceland.[210] The government of Canada also reported in late June and July, of the travelers arriving by air who test positive for COVID-19, a substantial proportion were BA.5.2.1.[211] BF.7 is a shortened version of the sub-variants full name, which is BA.5.2.1.7. This sub-variant is part of Omicron's BA.5 variant, which had the highest number of reported cases globally, accounting for 76.2% of all cases.[212]

BQ.1 and BQ.1.1

[edit]

In October 2022, two BA.5 subvariants were found: BQ.1 (or B.1.1.529.5.3.1.1.1.1.1) and BQ.1.1 (or B.1.1.529.5.3.1.1.1.1.1.1).[213][214][215] The variants were originally most prevalent in France.[216] As of 17 November, 93% of sequences in France were Omicron sub-lineage BA.5 and among the BA.5 sub-lineages, BQ.1.1 continued to rise (32% vs 25% in the prior week).[217] In November 2022 in the US it was reported the variants were accounting for 44% of new infections. Early laboratory tests found that these subvariants were better at escaping first and booster vaccines than previous variants.[218]

Transmission

[edit]
False-color transmission electron micrograph of an Omicron variant coronavirus, shown in pink, replicating within the cytoplasm of an infected Vero cell

In humans

[edit]

In January 2022, William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, compared the contagiousness of the Omicron variant to that of the measles.[219]

On 15 December 2021, Jenny Harries, head of the UK Health Security Agency, told a parliamentary committee that the doubling time of COVID-19 in most regions of the UK was now less than two days despite the country's high vaccination rate. She said that the Omicron variant of COVID-19 is "probably the most significant threat since the start of the pandemic", and that the number of cases in the next few days would be "quite staggering compared to the rate of growth that we've seen in cases for previous variants".[220]

A 2021 study suggested that mutations that promote breakthrough infections or antibody-resistance "like those in Omicron" could be a new mechanism for viral evolution success of SARS-CoV-2 and that such may become a dominating mechanism of its evolution.[221] A preprint supports such an explanation of Omicron's spread, suggesting that it "primarily can be ascribed to the immune evasiveness rather than an inherent increase in the basic transmissibility".[222][223] Studies showed the variant to escape the majority of existing SARS-CoV-2 neutralizing antibodies, including those in sera from vaccinated and convalescent individuals.[224][225][226][227] Nevertheless, existing vaccines were expected to protect against severe illness, hospitalizations, and deaths due to Omicron[228] and, on an individual level, the Omicron variant is milder than earlier variants that evolved when the antibody/vaccination share was lower than it was when Omicron emerged.[229]

In contrast to other investigated variants, Omicron showed substantial, population-level, evasion of immunity from prior infection as well as a higher ability to evade immunity induced by vaccines.[230]

Later research found that the spread of Omicron likely contributed to significant natural immunity to reinfection.[231]

In non-human animals

[edit]

In February 2022, the first confirmed case infecting a wild animal was confirmed by researchers at Pennsylvania State University in white-tailed deer in Staten Island, N.Y.[232]

Surfaces

[edit]

Although transmission via fomites is rare, preliminary data indicate that the variant lasts for 194 hours on plastic surfaces and 21 hours on skin, compared with just 56 and 7 hours, respectively, for the original strain.[233][234]

Vaccine effectiveness

[edit]

Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) mRNA vaccines provide reduced protection against asymptomatic disease but do reduce the risk of serious illness.[235][236][237] On 22 December 2021, the Imperial College COVID-19 Response Team reported an about 41% (95% CI, 3745%) lower risk of a hospitalization requiring a stay of at least 1 night compared to the Delta variant, and that the data suggested that recipients of 2 doses of the Pfizer–BioNTech, the Moderna or the Oxford–AstraZeneca vaccine were substantially protected from hospitalization.[238] In January 2022, results from Israel suggested that a fourth dose is only partially effective against Omicron. Many cases of infection broke through, albeit "a bit less than in the control group", even though trial participants had higher antibody levels after the fourth dose.[239] On 23 December 2021, Nature indicates that, though Omicron likely weakens vaccine protection, reasonable effectiveness against Omicron may be maintained with currently available vaccination and boosting approaches.[240][241]

In December, studies, some of which using large nationwide datasets from either Israel and Denmark, found that vaccine effectiveness of multiple common two-dosed COVID-19 vaccines is substantially lower against the Omicron variant than for other common variants including the Delta variant, and that a new (often a third) dose – a booster dose – is needed and effective, as it substantially reduces deaths from the disease compared to cohorts who received no booster but two doses.[242][243][244][245][246][247]

Vaccines continue to be recommended for Omicron and its subvariants. Professor Paul Morgan, immunologist at Cardiff University said, "I think a blunting rather than a complete loss [of immunity] is the most likely outcome. The virus can't possibly lose every single epitope on its surface, because if it did that spike protein couldn't work any more. So, while some of the antibodies and T cell clones made against earlier versions of the virus, or against the vaccines may not be effective, there will be others, which will remain effective. (...) If half, or two-thirds, or whatever it is, of the immune response is not going to be effective, and you're left with the residual half, then the more boosted that is the better."[248] Professor Francois Balloux of the Genetics Institute at University College London said, "From what we have learned so far, we can be fairly confident that – compared with other variants – Omicron tends to be better able to reinfect people who have been previously infected and received some protection against COVID-19. That is pretty clear and was anticipated from the mutational changes we have pinpointed in its protein structure. These make it more difficult for antibodies to neutralise the virus."[249]

BA.1 and BA.2

[edit]

A January 2022 study by the UK Health Security Agency found that vaccines afforded similar levels of protection against symptomatic disease by BA.1 and BA.2, and in both it was considerably higher after two doses and a booster than two doses without booster,[250][251] though because of the gradually waning effect of vaccines, further booster vaccination may later be necessary.[170]

BA.4 and BA.5

[edit]

In May 2022, a preprint indicated Omicron subvariants BA.4 and BA.5 could cause a large share of COVID-19 reinfections, beyond the increase of reinfections caused by the Omicron lineage, even for people who were infected by Omicron BA.1 due to increases in immune evasion, especially for the unvaccinated. However, the observed escape of BA.4 and BA.5 from immunity by a BA.1 infection is more moderate than of BA.1 against studied prior cases of immunity (such as immunity from specific vaccines).[252][253]

Immunity from an Omicron infection for unvaccinated and previously uninfected was found to be weak "against non-Omicron variants",[254] albeit at the time Omicron is, by a large margin, the dominant variant in sequenced human cases.[255]

BQ.1 and BQ.1.1

[edit]

Subvariants BQ.1 and BQ.1.1 were found in late 2022 to be better at escaping first and booster vaccines than previous variants, and to have further reduced the effectiveness of monoclonal antibody treatments.[256]

Vaccine adjustments

[edit]

In June 2022, Pfizer and Moderna developed bivalent vaccines to protect against the SARS-CoV-2 wild-type and the Omicron variant. The bivalent vaccines are well-tolerated and offer immunity to Omicron superior to previous mRNA vaccines.[257] In September 2022, the United States Food and Drug Administration (FDA) authorized the bivalent vaccines for use in the US.[258][259][260]

In June 2023, the FDA advised manufacturers that the 2023–2024 formulation of the COVID‑19 vaccines for use in the US be updated to be a monovalent COVID‑19 vaccine using the XBB.1.5 lineage of the Omicron variant.[261][262] In June 2024, the FDA advised manufacturers that the 2024–2025 formulation of the COVID‑19 vaccines for use in the US be updated to be a monovalent COVID‑19 vaccine using the JN.1 lineage.[263]

Signs and symptoms

[edit]

Loss of taste and smell seem to be uncommon compared to other strains.[5][6] A unique reported symptom of the Omicron variant is night sweats,[7][264] particularly with the BA.5 subvariant.[265][266] A study performed between 1 and 7 December 2021 by the Center for Disease Control found that: "The most commonly reported symptoms [were] cough, fatigue, and congestion or runny nose" making it difficult to distinguish from a less damaging variant or another virus.[267] Research published in London on 25 December 2021 suggested the most frequent symptoms stated by users of the Zoe Covid app were "a runny nose, headaches, fatigue, sneezing and sore throats."[4]

A British Omicron case-control observational study until March 2022 showed a reduction in odds of long COVID with the Omicron variant versus the Delta variant of 0·24–0·5 depending on age and time since vaccination.[268]

Virulence

[edit]

As of 6 January 2022, Omicron multiplied around 70 times faster than the Delta variant in the bronchi (lung airways) but evidence suggested it is less severe than previous variants, especially compared to Delta,[269][229] since it might be less able to penetrate deep lung tissue.[270] As of January 2022, in southern California infections were 91 percent less fatal than the delta variant, with 51 percent less risk of hospitalization.[271] However, the estimated difference in the intrinsic risk of hospitalization in England largely decreased to 0–30 percent, when reinfections were excluded.[272]

As of 21 January 2022 the risk of hospitalization was the same in BA.1 and BA.2 based on reviews from Denmark, India, South Africa and the United Kingdom.[273][149][165][274] Norwegian studies showed that the amount of virus in the upper airways was similar in those infected with BA.1 and BA.2.[167]

Diagnosis

[edit]

As of November 2021, the chance of detecting an Omicron case particularly depended on a country's sequencing rate, with South Africa sequencing far more samples than any other country in Africa, but at a considerably lower rate than most Western nations.[275][276] Sequencing the virus from a sample can take weeks limiting the early availability of data.[277]

In January 2022 the medicine and therapeutic regulatory agency Therapeutic Goods Administration (TGA) of the Australian Government had only tested one of their 23 approved COVID-19 rapid antigen tests (RAT) to verify it detected Omicron.[278] The TGA later updated their approved list to show that all RATs which detected other variants could detect Omicron infections.[279] In June 2022, the German federal Paul-Ehrlich-Institute published their findings, that most RATs detected the Omicron Variant.[280]

PCR testing

[edit]

In December 2021, the US FDA published guidelines on how PCR tests would be affected by Omicron.[281] Tests that detect multiple gene targets were to continue to identify the testee as positive for COVID-19. S-gene dropout or target failure was proposed as a shorthand way of differentiating Omicron from Delta. besides sequencing and genotyping.[282]

As of December 2021, Denmark and Norway have regarded cases found by their variant qPCR test, which is relatively fast and checks several genes,[283] as sufficient for counting it as Omicron, before full sequencing.[284][285]

BA.1 and BA.2 differences

[edit]

As of 7 December 2021 it was known that BA.2, unlike BA.1, lacks the characteristic S-gene target failure (SGTF) causing deletion (Δ69-70), by which many qPCR tests have been able to rapidly detect a case as an Omicron (or Alpha) variant, from the previously dominant Delta variant.[286][287] Thus, countries which primarily rely on SGTF for detection may overlook BA.2,[286] and British authorities consider SGTF alone as insufficient for monitoring the spread of Omicron.[273] This has resulted in it having been nicknamed 'Stealth Omicron',[273] but because BA.2 still can be separated from other variants through normal full sequencing, or checks of certain other mutations, the nickname is not quite accurate.[140][288] As of January 2022, some countries, such as Denmark and Japan, have been using a variant qPCR which tests for several mutations, including L452R.[283][161] It can also distinguish Delta, which has L452R,[289] and all Omicron subvariants, which do not have L452R.[290][147] As Omicron became dominant and the Delta variant became rare in early 2022, the SGTF mutation that had made Delta and BA.2 similar in qPCR tests was found to be useful for separating BA.1 and BA.2 from each other.[291]

Treatment

[edit]

As of 28 November 2021, Corticosteroids such as dexamethasone and IL6 receptor blockers such as tocilizumab (Actemra) were known to be effective for managing patients with the earlier strains of severe COVID-19 but the impact on the effectiveness of other treatments was being assessed.[292][293]

Relating to monoclonal antibodies (mAbs) treatments, similar testing and research is ongoing. Preclinical data on in vitro pseudotyped virus data demonstrate that some mAbs designed to use highly conserved epitopes retain neutralizing activity against key mutations of Omicron substitutions.[294] Similar results are confirmed by cryo-electron microscopy and X-ray data, also providing the structural approach and molecular basis for the evasion of humoral immunity exhibited by Omicron antigenic shift as well as the importance of targeting conserved epitopes for vaccine and therapeutics design. While 7 clinical mAbs or mAb cocktails experienced loss of neutralizing activity of 1-2 orders of magnitude or greater relative to the prototypic virus, the S309 mAb, the parent mAb of sotrovimab, neutralized Omicron with only 2-3-fold reduced potency.[295]

As of December 2021, most monoclonal antibodies had lost in vitro neutralizing activity against Omicron, with only 3 out of 29 mAbs examined in another study retaining unaltered potency. Furthermore, a fraction of broadly neutralizing sarbecovirus mAbs neutralized Omicron through recognition of antigenic sites outside the RBM, including sotrovimab (VIR-7831), S2X259 and S2H97.[296] However, sotrovimab was not fully active against the BA.2 Omicron sublineage, and in March 2022 the office of the U.S. ASPR stopped distributing the antibody treatment to states where BA.2 was dominant.[297] February 2022 data suggested Omicron caused significant humoral immune evasion, while neutralizing antibodies targeting the sarbecovirus conserved region remained most effective.[298]

Epidemiology

[edit]

On 26 November 2021, the South African National Institute for Communicable Diseases announced that 30,904 COVID-19-tests (in one day) detected 2,828 new COVID-19 infections (a 9.2% positivity rate).[299] One week later, on 3 December 2021, the NICD announced that 65,990 COVID-19 tests had found 16,055 new infections (5.7 times as many as seven days before; positive rate 24.3%) and that 72 percent of them were found in Gauteng.[300][301] This province of South Africa is densely populated at about 850 inhabitants per km2. Gauteng's capital Johannesburg is a megacity (about 5.5 million inhabitants in the city itself plus 9.5 million in the urban region).[citation needed]

In November 2021, the transmissibility of the Omicron variant, as compared to the Delta variant or other variants of the COVID-19 virus, was still uncertain.[292] Omicron is frequently able to infect previously COVID-19-positive people.[302][303]

It has been estimated the Omicron variant diverged in late September or early October 2021, based on Omicron genome comparisons.[304] Sequencing data suggests that Omicron had become the dominant variant in South Africa by November 2021, the same month where it had been first identified in the country.[305][306]

Phylogeny suggests a recent emergence. Data from South Africa suggests that Omicron has a pronounced growth advantage there. However, this may be due to transmissibility or immune escape related, or both."[307] Also the serial interval plays a role in the growth.

Detectable changes in levels of COVID-19 in wastewater samples from South Africa's Gauteng province were seen as early as 17–23 October (week 42).[308] The National Institute for Communicable Diseases reports that children under the age of 2 make up 10% of total hospital admissions in the Omicron point of discovery Tshwane in South Africa.[309] Data on the S gene target failure (SGTF) of sampled cases in South Africa indicates a growth of 21% per day relative to Delta, generating an increased reproduction number by a factor of 2.4.[a] Omicron became the majority strain in South Africa around 10 November.[310][311] Another analysis showed 32% growth per day in Gauteng, South Africa, having become dominant there around 6 November.[312]

In the UK, the logarithmic growth rate of Omicron-associated S gene target failure (SGTF) cases over S gene target positive (SGTP) cases was estimated at 0.37 per day,[b] which is exceptionally high.[313] Furthermore, by 14 December it appears to have become the most dominant strain.[c][314] Without presuming behavior change in response to the variant, a million infections per day by 24 December are projected for a 2.5 days doubling time.[d][282] In Denmark, the growth rate has been roughly similar with a doubling time of about 2–3 days, it having become the most prevalent strain on 17 December.[315][316][317] Switzerland is not far behind.[318] In Germany Omicron became the most prevalent variant on 1 January.[319] In Scotland, Omicron apparently became the most prevalent variant on 17 December.[320][321] In the Canadian province of Ontario it became the most prevalent strain on 13 December.[322] In the US, the variant appears to have become the most prevalent strain on 18 December, growing at 0.24 per day.[323] In Portugal, Omicron had reached 61.5% of cases on 22 December.[324] In Belgium, the strain has become the most prevalent on 25 December,[325] and in the Netherlands on 28 December.[326] In Italy, it had reached 28% of cases on 20 December and was doubling every two days,[327] while it became the dominant variant in Norway on 25 December.[328] In France, it made up about 15% of COVID-19 cases in mid-December, but around 27 December it had increased to more than 60%.[329][330] Researchers recommend sampling at least 5% of COVID-19 patient samples in order to detect Omicron or other emerging variants.[331]

During January 2022, in Denmark the BA.2 variant grew at ~0.10 per day (+11% per day) as a ratio to BA.1 (the legacy Omicron variant), and became the dominant strain in week 2, 2022.[164] In the United Kingdom, the BA.2 variant was growing at ~0.11 per day (+12% per day) as a ratio to BA.1.[332]

On 13 January 2022, the BBC reported that the hospitalization rate was higher in the US and Canada than in Europe and South Africa. This was attributed to a combination of a greater number of elderly people than in South Africa, greater prevalence of comorbidities such as hypertension and obesity than in Europe, higher indoor transmission due to the winter, lower vaccination rate in the US than in Europe and Canada, and a possible still high prevalence of the Delta variant, which more often leads to hospitalization.[333]

Reported cases

[edit]
Confirmed and suspected cases by country and territory
Country/Territory Confirmed cases (PANGOLIN)[334]
as of 5 May 2022
Confirmed cases (GISAID)[335]
as of July 29, 2022
Confirmed cases (other sources)
As of 24 June 2022
Suspected cases
 United States 999,565 1,431,772 62,480[336]As of January 8, 2022
 United Kingdom 999,565 1,253,700 246,780[337] 600,041[337]
 Germany 207,407 365,837 268,661[338]
 Austria 6,809 57,379 290,378[339][340]
 Denmark 196,746 264,998 66,563[341]
 France 83,564 184,880 5,591[342]
 Canada 73,584 147,223 174,248[343]
 Japan 67,203 153,110 12,453[344]
 India 37,542 81 017 8,209[345][346]
 Australia 33,905 80,013 11,071[347]
 Norway 14,729 24,529 45,296[284]
 Thailand 6,778 12,811 5,397[348]
 Indonesia 9,761 12,028 3,779[349]
 Singapore 4,543 7,300 4,322[350][351][352][353]
 Estonia 1,982 3,778 3,857[354][355][356]
 Israel 22,164 60,435 1,741[357][358] 861[357]
 South Africa 9,631 16,451 1,095[359] 19,070[360]
 South Korea 7,731 27,705 1,318[361]
 Spain 24,607 31,992 51[338][362]
 Belgium 26,448 30,865 121[339][362]
 Sweden 38,397 42,525 53.760[363]
  Switzerland 30,034 32,635 19,269[339][364]
 Argentina 2,228 2,583 455[365][366] 80[367]
 Botswana 931 1,594 23[368]
 Netherlands 24,381 26,601 123[369][362]
 Ireland 24,654 29,518 29,576[370]
 Gibraltar 112 122 24[371]
 Iceland 84[372]
 Italy 23,707 27,292 84[373]
 Chile 4,097 4,572 684[374][375][376]
 Portugal 7,683 8,870 69[377][362] 6[378][339]
 Morocco 128 138 76[379] 246[379]
 Zimbabwe 185 219 50[380]
 Ghana 441 605 33[368]
 Brazil 27,787 32,224 203[381]
 Finland 4,029 5,239 523[382][383]
 Cyprus 31[384][385]
 Kenya 1,653 2,329 27[386]
 Russia 1,273 1,738 8,239[387]
 Cayman Islands 44[388] 59[388]
 Uganda 12 38 25[389][390]
 Mexico 12,736 13,678 1[391]
 New Zealand 3,169 3,739 116[392]
 Namibia 125 213 18[393]
 Hong Kong 1,432 3,526 102[394][395]
 Senegal 14 229 3[396]
 Mozambique 133 176 2[397] 2[336]
 Greece 3,268 3,276 17[339][398]
 Bermuda 24 144[399][400]
 Latvia 407 407 644[401][362][402]
 Romania 4,034 4,282 25[403][404][405]
 Malaysia 5,330 7,353 245[406]
 Zambia 141 365 11[407]
 Nigeria 827 1,638 6[408]
 Czech Republic 13,264 15,147 10[339][409][362]
 Kosovo 245 262 9[410]
 Slovenia 15,684 17,106 1,418[411][362][412][413]
 Lebanon 85 107 433[414][415] 16[414]
 Reunion 2,014 2,402 2[416]
 Mauritius 763 7[336]
 Poland 31,766 33,327 1[417]
 Rwanda 70 178 6[417]
 Turkey 9,135 10,239 6[418]
 Montenegro 142 211 5[419]
 Cambodia 950 974 31[420]
 Peru 5,653 5,960 10,032[421]
 Jordan 83 83 832[422]
 China 96 96 4[423][424][425]
 Cuba 92[426][427][428]
 Croatia 10,379 11,742 3[339]
 Egypt 15 40 3[417]
 Malawi 133 166 3[429]
 Palestinian Territory 5 9 126[430][431]
 Taiwan 34 34 89[432]
 Lithuania 7,063 9,136 2[433]
 Colombia 1,629 3,816 3[434]
 Slovakia 13,501 15,625 3[435]
 Trinidad and Tobago 291 499 1[436]
 Puerto Rico 3,166 3,558 1[437]
 Fiji 2[438]
   Nepal 255 349 2[439]
 Myanmar 25 28 4[440]
 Philippines 1,281 1,549 535[441][442][443][444][445][446]
 Northern Cyprus 9[447]
 Bangladesh 690 998 10[448]
 Liechtenstein 246 736 1[449] 3[336]
 Hungary 28 28 61[450][362][451]
 Oman 71 85 2[452]
 Pakistan 359 463 75[453][454]
 Sri Lanka 626 927 1[455]
 Georgia (country) 718 822 600[456]
 Algeria 61 73 1[417]
 Bahrain 1[457]
 Ecuador 1,177 1,561 1[458]
 Kuwait 54 72 1[459]
 Luxembourg 4,031 11,149 1[339]
 Maldives 281 5[460][461]
 Sierra Leone 1 1[462]
 Saudi Arabia 28 30 1[463]
 Tunisia 51 52 1[464]
 United Arab Emirates 1 1[465]
 Iran 595 682 467[466]
 Ukraine 73 99 1[467]
 Panama 821 822 1[468]
 Costa Rica 1,430 1,529 1[469]
 Aruba 61 61 1[470]
 North Macedonia 46 47 9[471][472]
 Vietnam 1,085 1,790 108[473]
 Brunei 1,163 1,253 8[474]
 Malta 138 162 2[475]
 Venezuela 60 62 7[476]
 French Guiana 366 20[477]
 Republic of the Congo 50 78 1[478]
 Qatar 267 290 4[479]
 Paraguay 122 139 3[480]
 Burkina Faso 17 2[481]
 Curacao 482 487 1[482]
 Saint Kitts and Nevis 16 2[483]
 Libya 2[484]
 Albania 1 1 1[485]
 Barbados 1 7 1[486]
 Saint Vincent and the Grenadines 62 1[487]
 Dominican Republic 69 73 1[488]
 Jamaica 443 622 1[489]
 Serbia 81 81 1[490]
 Tanzania 2 3 1[491]
 Togo 5[492]
 Belarus 71 4[493]
 Bosnia and Herzegovina 118 122 10[494]
 Angola 25 37 16[495]
 Democratic Republic of the Congo 34 204 1[496]
 Bulgaria 2,516 2,520 12[497]
 Mayotte 123 130 1[498]
 Martinique 593 1[499]
 Gambia 30 155 26[500]
 Seychelles 235 464[501]
 Saint Martin 224 240 2[502]
 Laos 1[503]
 Iraq 36 103 5[504]
 Mauritania 14[505]
 South Sudan 28 28 41[506]
 Ivory Coast 41 60 78[507]
 Cape Verde 152 175[508]
 Antigua and Barbuda 36 1[509]
 Gabon 1[510]
 Bolivia 2 7 1[511]
 Moldova 287 314 29[512]
 Kazakhstan 8 8 8[513]
 Guadeloupe 264 300 1[514]
 Azerbaijan 12 12 12[515]
 Suriname 81 96 146[501]
 Sint Maarten 479 753[501]
 British Virgin Islands 20 26 39[501]
 Mali 1 2
 Anguilla 20 24 30[501]
 Bonaire 400 692[501]
 Bhutan 14[516]
 Papua New Guinea 379 565 1[517]
 Mongolia 133 133 12[518]
 Antarctica 24[519]
 Uzbekistan 1[520]
 Saint Lucia 1 9 54[501]
 Burundi 1 28[501]
 American Samoa 35 84[501]
 Armenia 4 16 17[501]
 Guinea 48 167 159[501]
 Guam 168 274 348[501]
 Belize 223 240 441[501]
 Eswatini 124 133
 Djibouti 306 308 337[501]
 World total (170 countries and territories) 2,986,573 3,517,102 1,168,383 620,384


See also

[edit]

Notes

[edit]
  1. ^ With a presumed identical person-to-person serial interval of loge(2.4)/0.21 ~ 4.2 days, or a distribution thereof to the same effect.
  2. ^ Logarithmic growth rate of 0.37/day means that the log odds loge(SGTF/SGTP) is increasing by 0.37 in a day. So SGTF/SGTP was increasing by a multiplicative factor of exp(0.37) ~ 1.45. This is substantially higher than a naive increase to 100%+37%. The difference is mathematically due to compound growth within the day, which does not imply that epidemically people are already infectious within a day. Rather, simplified (non-delay) differential equations are used for convenience for the modeling. This also indicates a doubling time of loge(2)/(0.37/day) ~ 1. days for the Omicron to Delta prevalence ratio.
  3. ^ Referring to ref 12 in the reference, where the x-axis is crossed at 14 December.
  4. ^ A doubling time of 2.5 days corresponds to an exponential growth rate of ln(2)/(2.5 days) ~ 0.28/day. Direct comparison to the logistic growth rate needs to take the growth/decline of Delta into account.

References

[edit]
  1. ^ a b c Yadav PD, Gupta N, Potdar V, Mohandas S, Sahay RR, Sarkale P, et al. (January 2022). An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens. pp. 2022–01.02.474750. doi:10.1101/2022.01.02.474750. Archived from the original on 16 January 2022. Retrieved 16 January 2022.
  2. ^ a b Padin M (17 January 2022). "Feeling light-headed may be an early indication you have Omicron Covid variant". Daily Mirror. Archived from the original on 28 January 2022. Retrieved 30 January 2022.
  3. ^ Poudel S, Ishak A, Perez-Fernandez J, Garcia E, León-Figueroa DA, Romaní L, et al. (December 2021). "Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – What is known so far?". Travel Medicine and Infectious Disease. 45: 102234. doi:10.1016/j.tmaid.2021.102234. PMC 8666662. PMID 34896326.
  4. ^ a b c d Adams R (24 December 2021). "Omicron's cold-like symptoms mean UK guidance 'needs urgent update'". The Guardian. Archived from the original on 25 December 2021.
  5. ^ a b "Omicron Symptoms: Here's How They Differ From Other Variants". NBC Chicago. 7 January 2022. Archived from the original on 24 January 2022. Retrieved 30 January 2022.
  6. ^ a b Slater, Jack (23 January 2022). "Is a change to your taste or smell a sign of Omicron?". Metro. Archived from the original on 26 January 2022. Retrieved 30 January 2022.
  7. ^ a b Scribner H (21 December 2021). "Doctor reveals new nightly omicron variant symptom". Deseret News. Archived from the original on 2 January 2022. Retrieved 1 January 2022.
  8. ^ "Does Omicron cause less damage to the lungs?". medicalnewstoday.com. 14 January 2022. Archived from the original on 9 February 2022. Retrieved 22 August 2023.
  9. ^ Murrison P (18 January 2022). "Omicron symptoms: Three distinctive rashes to watch for". Express.co.uk. Archived from the original on 12 January 2022. Retrieved 30 January 2022.
  10. ^ a b c Quarleri J, Galvan V, Delpino MV (February 2022). "Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load". GeroScience. 44 (1): 53–56. doi:10.1007/s11357-021-00500-4. PMC 8683309. PMID 34921354.
  11. ^ Gowrisankar A, Priyanka TM, Banerjee S (10 January 2022). "Omicron: a mysterious variant of concern". European Physical Journal Plus. 137 (1): 100. Bibcode:2022EPJP..137..100G. doi:10.1140/epjp/s13360-021-02321-y. PMC 8743750. PMID 35036269.
  12. ^ a b Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M (July 2022). "Advances in the Omicron variant development". Journal of Internal Medicine. 292 (1): 81–90. doi:10.1111/joim.13478. PMC 9115048. PMID 35289434.
  13. ^ a b Yao L, Zhu KL, Jiang XL, Wang XJ, Zhan BD, Gao HX, et al. (June 2022). "Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection". The Lancet. Infectious Diseases. 22 (8): 1116–1117. doi:10.1016/s1473-3099(22)00410-8. PMC 9212811. PMID 35738299.
  14. ^ Ahmed SF, Quadeer AA, McKay MR (January 2022). "SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron". Viruses. 14 (1): 79. doi:10.3390/v14010079. PMC 8781795. PMID 35062283.
  15. ^ Al Jurdi A, Gassen RB, Borges TJ, Lape IT, Morena L, Efe O, et al. (June 2022). "Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients". pp. 1282–1286. medRxiv 10.1101/2022.01.03.22268649v1.
  16. ^ Altarawneh HN, Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Yassine HM, et al. (July 2022). "Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections". The New England Journal of Medicine. 387 (1): 21–34. doi:10.1056/NEJMoa2203965. PMC 9258753. PMID 35704396. S2CID 249677809.
  17. ^ Nemet I, Kliker L, Lustig Y, Zuckerman N, Erster O, Cohen C, et al. (February 2022). "Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection". The New England Journal of Medicine. 386 (5): 492–494. doi:10.1056/NEJMc2119358. PMC 8823651. PMID 34965337.
  18. ^ Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, et al. (June 2022). "BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection". Nature. 608 (7923): 593–602. Bibcode:2022Natur.608..593C. doi:10.1038/s41586-022-04980-y. PMC 9385493. PMID 35714668.
  19. ^ Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J, Rowe M, et al. (July 2022). "Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5". The New England Journal of Medicine. 387 (1): 86–88. doi:10.1056/NEJMc2206576. PMC 9258748. PMID 35731894. S2CID 249956777.
  20. ^ Patel V (27 November 2021). "How Omicron, the New Covid-19 Variant, Got Its Name". The New York Times. ISSN 0362-4331. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  21. ^ Tcholakian D (15 December 2021). "'Omni is everywhere': why do so many people struggle to say Omicron?". The Guardian. Archived from the original on 23 December 2021. Retrieved 23 December 2021.
  22. ^ Zimmer B (2 December 2021). "'Omicron': Greek's 'Little O' Will Loom Larger Now". Wall Street Journal. ISSN 0099-9660. Archived from the original on 3 December 2021. Retrieved 23 December 2021. President Joe Biden stumbled over the pronunciation in a press conference on Monday, calling the variant "omnicron" with an extra "n" sound. It has also been frequently misspelled that way online. The confusion is understandable, since we're more familiar with words that have the Latin prefix "omni-" meaning "all," as in "omnipresent" or "omnivore."
  23. ^ "In focus". gisaid.org. GISAID. 28 November 2021. Archived from the original on 21 January 2021. Retrieved 28 November 2021. The unique mix of spike amino acid changes in Omicron GR/484A (B.1.1.529) is of interest as it comprises several that were previously known to affect receptor binding and antibody escape.
  24. ^ a b "Variant: 21K (Omicron)". covariants.org. CoVariants. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021. Variant 21K (Omicron) appears to have arisen in November 2021, possibly in South Africa.
  25. ^ a b Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. (March 2022). "Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa". Nature. 603 (7902): 679–686. Bibcode:2022Natur.603..679V. doi:10.1038/s41586-022-04411-y. PMC 8942855. PMID 35042229.
  26. ^ Dyer O (December 2021). "Covid-19: South Africa's surge in cases deepens alarm over omicron variant". BMJ. 375: n3013. doi:10.1136/bmj.n3013. PMID 34862184. S2CID 244842008.
  27. ^ a b Gu H, Krishnan P, Ng DY, Chang LD, Liu GY, Cheng SS, et al. (February 2022). "Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021". Emerging Infectious Diseases. 28 (2): 460–462. doi:10.3201/eid2802.212422. PMC 8798678. PMID 34860154.
  28. ^ a b Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. (February 2022). "Considerable escape of SARS-CoV-2 Omicron to antibody neutralization". Nature. 602 (7898): 671–675. Bibcode:2022Natur.602..671P. doi:10.1038/s41586-021-04389-z. PMID 35016199. S2CID 256823009.
  29. ^ a b Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK, Abdel-Moneim AS (May 2022). "Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus-2 Omicron Variant of Concern". Journal of Medical Virology. 94 (5): 2160–2166. doi:10.1002/jmv.27611. PMC 9015611. PMID 35050521.
  30. ^ a b Wei C, Shan KJ, Wang W, Zhang S, Huan Q, Qian W (December 2021). "Evidence for a mouse origin of the SARS-CoV-2 Omicron variant". Journal of Genetics and Genomics = Yi Chuan Xue Bao. 48 (12): 1111–1121. doi:10.1016/j.jgg.2021.12.003. PMC 8702434. PMID 34954396.
  31. ^ a b Alkhatib M, Salpini R, Carioti L, Ambrosio FA, D'Anna S, Duca L, et al. (April 2022). Perez DR (ed.). "Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile". Microbiology Spectrum. 10 (2): e0273221. doi:10.1128/spectrum.02732-21. PMC 9045195. PMID 35352942.
  32. ^ a b c Tarcsai KR, Corolciuc O, Tordai A, Ongrádi J (June 2022). "SARS-CoV-2 infection in HIV-infected patients: potential role in the high mutational load of the Omicron variant emerging in South Africa". GeroScience. 44 (5): 2337–2345. doi:10.1007/s11357-022-00603-6. PMC 9225796. PMID 35739343.
  33. ^ "The mystery of where omicron came from — and why it matters". NPR. 1 December 2021. Archived from the original on 9 December 2021. Retrieved 8 December 2021.
  34. ^ Zungu N, Mabaso M, Ramlagan S, Simbayi L, Moyo S, Shisana O, et al. (May 2022). "Is There Risk Compensation among HIV Infected Youth and Adults 15 Years and Older on Antiretroviral Treatment in South Africa? Findings from the 2017 National HIV Prevalence, Incidence, Behaviour and Communication Survey". International Journal of Environmental Research and Public Health. 19 (10): 6156. doi:10.3390/ijerph19106156. PMC 9141949. PMID 35627693.
  35. ^ Fischer, Carlo; et al. (2022). "Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa". Science. 378 (6623): eadd8737. doi:10.1126/science.add8737. PMID 36454863. S2CID 254150265. (Retracted, see doi:10.1126/science.adg2821, PMID 36537892,  Retraction Watch. If this is an intentional citation to a retracted paper, please replace {{retracted|...}} with {{retracted|...|intentional=yes}}.)
  36. ^ Mallapaty, Smriti (6 December 2022). "Surprising Omicron origins study comes under scrutiny". Nature. 612 (7940): 387–388. Bibcode:2022Natur.612..387M. doi:10.1038/d41586-022-04357-1. PMID 36474049. S2CID 254402519.
  37. ^ "Study on the origins of Omicron retracted". www.charite.de. 20 December 2022. Archived from the original on 24 December 2022. Retrieved 24 December 2022. In a subsequent analysis of residual samples, they were found to be contaminated. It is no longer possible to establish the source of the contamination.
  38. ^ "'We made a mistake.' Omicron origin study retracted after widespread criticism". science.org. 20 December 2022. Archived from the original on 24 December 2022. Retrieved 24 December 2022. But Kristian Andersen [...] says the gradual evolution theory was already "off the table" before the paper was published.
  39. ^ Cowan K (29 November 2021). "Inside SA leg of Omicron variant discovery: A single test result, a missing gene, and an email". News24. Archived from the original on 2 December 2021. Retrieved 2 December 2021.
  40. ^ a b Callaway E (December 2021). "Heavily mutated Omicron variant puts scientists on alert". Nature. 600 (7887): 21. Bibcode:2021Natur.600...21C. doi:10.1038/d41586-021-03552-w. PMID 34824381. S2CID 244660616. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  41. ^ a b @BNODesk (26 November 2021). "Statement from Israel's health ministry reporting 1 confirmed case of new coronavirus variant B.1.1.529" (Tweet). Retrieved 26 November 2021 – via Twitter.
  42. ^ ינקו, אדיר; שומפלבי, אטילה (26 November 2021). "מחוסנת ב-3 מנות ואישה שנסעה לאילת באוטובוס: המאומתים לזן החדשt". Ynet (in Hebrew). Archived from the original on 27 November 2021. Retrieved 28 November 2021. "4 מאומתים לווריאנט החדש התגלו בארץ, רה"מ יקיים מסיבת עיתונאים ב-14:30" translated: "4 verified for the new variant were discovered in the country, the prime minister will hold a press conference at 14:30
  43. ^ Four cases of the new COVID-19 variant recorded in Botswana Archived 26 November 2021 at the Wayback Machine, 25 November 2021, Mmegi Online, accessed 26 November 2021
  44. ^ Kesselgruber K (27 November 2021). "Flughafen Frankfurt: Person mit Omikron-Verdacht war vollständig geimpft" [Frankfurt airport: Person suspected to be infected with Omicron Variant was fully vaccinated]. Frankfurter Rundschau (in German). Archived from the original on 27 November 2021. Retrieved 27 November 2021.
  45. ^ "UK, Germany and Italy detect Omicron coronavirus variant cases". Reuters. 27 November 2021. Archived from the original on 27 November 2021. Retrieved 27 November 2021.
  46. ^ "Coronavirus variant Omicron found in 13 positive tests so far | RIVM". www.rivm.nl. Archived from the original on 6 December 2021. Retrieved 6 December 2021.
  47. ^ "Actuele informatie over COVID-19 | RIVM" [Current information about COVID-19 | RIVM]. www.rivm.nl (in Dutch). 4 December 2021. Archived from the original on 6 April 2020. Retrieved 6 December 2021.
  48. ^ "61 travellers from South Africa in Netherlands positive for COVID-19 – authorities". Reuters. Amsterdam. 27 November 2021. Archived from the original on 26 November 2021. Retrieved 27 November 2021.
  49. ^ "Travellers test positive to Omicron COVID-19 strain after arriving in Sydney from southern Africa, NSW Health says". ABC News. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  50. ^ "To personer er indrejst i Danmark med coronavarianten Omikron" [Two people have entered Denmark with the corona variant Omicron]. www.bt.dk (in Danish). 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  51. ^ Ritzau A (28 November 2021). "Nu er det bekræftet: To personer smittet med Omikron rejst ind i Danmark" [Now it has been confirmed: Two people infected with Omicron traveled into Denmark]. ekstrabladet.dk (in Danish). Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  52. ^ "Austria detects suspect Omicron case as Europe battles virus surge". WION. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  53. ^ "Omicron variant found in UK, Germany, Czech Republic". New York Post. 28 November 2021. Archived from the original on 27 November 2021. Retrieved 28 November 2021.
  54. ^ "Canada, Netherland, Australia latest countries reporting cases of omicron COVID-19 variant". ABC13. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  55. ^ Perera A (29 November 2021). "COVID-positive repatriation flight arrival to the Northern Territory tests positive to Omicron variant". ABC News. Archived from the original on 29 November 2021. Retrieved 29 November 2021.
  56. ^ Nguyen K (29 November 2021). "NSW Health confirms two more Omicron COVID-19 cases in travellers from southern Africa". ABC News. Archived from the original on 29 November 2021. Retrieved 29 November 2021.
  57. ^ "Live updates: Omicron variant". Cable News Network. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 29 November 2021.
  58. ^ "Första fallet av omikron upptäckt i Sverige" [The first case of omicron detection in Sweden]. www.aftonbladet.se (in Swedish). 29 November 2021. Archived from the original on 30 November 2021. Retrieved 29 November 2021.
  59. ^ "Spain detects first Omicron case, COVID-19 infections rise". Reuters. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021.
  60. ^ "Omicron variant found in two previous test samples | RIVM". www.rivm.nl. Archived from the original on 4 December 2021. Retrieved 6 December 2021.
  61. ^ "NSW records fifth case of Omicron COVID-19 variant as two more potential infections investigated". ABC News. 30 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021.
  62. ^ "Japan's first Omicron case may help portray PM Kishida as decisive". Reuters. 30 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021.
  63. ^ "Two Israeli doctors test positive for Omicron COVID variant". The Jerusalem Post. 30 November 2021. Archived from the original on 31 December 2021. Retrieved 30 November 2021.
  64. ^ "SP confirma terceiro caso da variante ômicron" [SP confirms third case of ômicron variant]. g1 (in Brazilian Portuguese). 1 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  65. ^ "O que se sabe sobre os primeiros casos confirmados da variante Ômicron no Brasil" [What is known about the first confirmed cases of the Ômicron variant in Brazil]. CNN Brasil (in Brazilian Portuguese). 30 November 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  66. ^ "Passa para 6 o número de casos suspeitos da variante Ômicron investigados no Brasil" [The number of suspected cases of the Ômicron variant investigated in Brazil goes to 6]. CNN Brasil (in Brazilian Portuguese). 30 November 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  67. ^ "Germany: Leipzig reports first Omicron variant case with no travel history". Free Press Journal. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  68. ^ Dahir A, Ezeamalu B, Pérez-Peña R (1 December 2021). "Ghana and Nigeria are the latest African countries to detect the Omicron variant". The New York Times. Archived from the original on 2 December 2021. Retrieved 2 December 2021.
  69. ^ "Nigeria confirms first cases of Omicron among travellers from South Africa". Reuters. 1 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  70. ^ Graff A (1 December 2021). "First case of omicron in US identified in San Francisco". San Francisco Chronicle. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  71. ^ Stark K, Rodriguez JF, Dillon RM (1 December 2021). "First U.S. Case of Omicron Variant Found in San Francisco Resident". San Francisco: KQED. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  72. ^ O'Donnell D (1 December 2021). "Case of Omicron variant confirmed in Ireland". RTÉ News and Current Affairs. Archived from the original on 3 December 2021. Retrieved 12 December 2021.
  73. ^ "South Korea reports five Omicron cases on flight from Nigeria". Reuters. 1 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  74. ^ "Dutch say 14 air passengers from S. Africa with Omicron were vaccinated". Reuters. 2 December 2021. Archived from the original on 2 December 2021. Retrieved 2 December 2021.
  75. ^ "Number of confirmed omicron cases as of 3 December". Folkehelseinstituttet. 4 December 2021. Archived from the original on 4 December 2021. Retrieved 4 December 2021.
  76. ^ "France now has 25 Omicron Covid variant cases – minister". Reuters. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 7 December 2021.
  77. ^ "Omicron sudah sampai ke Malaysia". Malaysiakini. 3 December 2021. Archived from the original on 3 December 2021. Retrieved 8 December 2021.
  78. ^ "Namibia detects Omicron coronavirus variant in 18 of 19 samples". Reuters. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 7 December 2021.
  79. ^ "Fijians test positive for Omicron variant – Govt". RNZ. 7 December 2021. Archived from the original on 6 December 2021. Retrieved 8 December 2021.
  80. ^ "Africa accounts for 46% of reported cases of Omicron, WHO official says". Reuters. 9 December 2021. Archived from the original on 10 December 2021. Retrieved 9 December 2021.
  81. ^ "Covid: First UK death recorded with Omicron variant". BBC News. 13 December 2021. Archived from the original on 20 December 2021. Retrieved 13 December 2021.
  82. ^ "First Omicron case detected in New Zealand". Ministry of Healfh. 16 December 2021. Archived from the original on 20 December 2021. Retrieved 16 December 2021.
  83. ^ "COVID: Germany records first death from omicron variant". DW. 23 December 2021. Archived from the original on 24 December 2021. Retrieved 23 December 2021.
  84. ^ "Australia: Omicron death, false negative COVID results". Al Jazeera. 27 December 2021. Archived from the original on 27 December 2021. Retrieved 27 December 2021.
  85. ^ "U.S. CDC estimates Omicron variant to be 58.6% of cases, revises projection". Reuters. 28 December 2021. Archived from the original on 6 March 2022. Retrieved 15 April 2022.
  86. ^ "S.Korea reports first deaths linked to Omicron coronavirus variant – Yonhap". Reuters. 3 January 2022. Archived from the original on 3 January 2022. Retrieved 3 January 2022.
  87. ^ a b "Statement on the update of WHO's working definitions and tracking system for SARS-CoV-2 variants of concern and variants of interest" (Statement). World Health Organization. 16 March 2023. Archived from the original on 8 June 2023. Retrieved 20 May 2023.
  88. ^ Goodman, Brenda (29 March 2022). "Omicron subvariant BA.2 is now the dominant strain of Covid-19 in the US, CDC says". CNN. Archived from the original on 29 March 2022. Retrieved 29 March 2022.
  89. ^ McDade, Aaron (29 March 2022). "Omicron BA.2 sub-variant now dominant in U.S., CDC says". Newsweek. Retrieved 29 March 2022.
  90. ^ CDC (28 March 2020). "COVID Data Tracker". Centers for Disease Control and Prevention. Archived from the original on 22 May 2021. Retrieved 29 March 2022.
  91. ^ Gretchen Vogel (22 May 2022). "New versions of Omicron are masters of immune evasion". Science. Archived from the original on 7 March 2023. Retrieved 20 November 2022.
  92. ^ "BioNTech says it could tweak Covid vaccine in 100 days if needed". The Guardian. 26 November 2021. Archived from the original on 27 November 2021. Retrieved 27 November 2021.
  93. ^ "Novavax developing vaccine that targets new COVID-19 variant". CBS Baltimore Staff. 30 November 2021. Archived from the original on 2 December 2021. Retrieved 4 December 2021.
  94. ^ Maddipatla M, Roy M (26 November 2021). "Maryland-Based Vaccine Manufacturer Developing COVID-19 Vaccine That Targets Omicron Variant". Reuters. Archived from the original on 28 November 2021. Retrieved 30 November 2021.
  95. ^ "Sputnik V maker: Vaccine could be adapted to fight omicron". ABC News. Moscow. Associated Press. 29 November 2021. Archived from the original on 2 December 2021. Retrieved 29 November 2021.
  96. ^ "Sinovac and world's Covid-19 vaccine makers 'ready' to produce Omicron jab". South China Morning Post. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 29 November 2021.
  97. ^ "Sinovac prevê atualização da Coronavac para variante Ômicron em até três meses" [Sinovac plans to update Coronavac to the Omicron variant within three months]. CNN Brazil (in Portuguese). 7 December 2021. Archived from the original on 9 December 2021. Retrieved 9 December 2021.
  98. ^ "Cuba to update domestic vaccine to battle Omicron". Al Jazeera. 2 December 2021. Archived from the original on 20 December 2021. Retrieved 20 December 2021.
  99. ^ Spencer K (10 January 2022). "Pfizer CEO says omicron vaccine will be ready in March". CNBC. Archived from the original on 26 January 2022. Retrieved 27 January 2022.
  100. ^ "Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern". WHO. 26 November 2021. Archived from the original on 26 November 2021.
  101. ^ "WHO cautions against imposing travel restrictions due to new variant". Reuters. Geneva. 26 November 2021. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  102. ^ "Implications of the emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA" (PDF). ecdc.europa.eu. Archived (PDF) from the original on 26 November 2021. Retrieved 26 November 2021.
  103. ^ a b "Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern". World Health Organization. 26 November 2021. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  104. ^ Nebehay S, Winning A (26 November 2021). "WHO names new COVID variant omicron, cautions against travel measures". Reuters. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  105. ^ a b "Omicron poses very high global risk, world must prepare -WHO". Reuters. Geneva. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021.
  106. ^ "Covid live updates today: Omicron variant, symptoms, vaccines efficacy, restrictions..." en.as. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  107. ^ "World closing its doors to African countries due to omicron". aa.com. 30 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021.
  108. ^ Yong C (26 November 2021). "Singapore bans travellers from 7 African countries; no cases of new Covid-19 variant here". The Straits Times. Singapore. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  109. ^ "Anvisa recomenda restrições de voo diante de nova variante de covid-19" [Anvisa recommends flight restrictions in view of the new covid-19 variant]. agenciabrasil.ebc.com.br. 26 November 2021. Archived from the original on 26 November 2021. Retrieved 27 November 2021.
  110. ^ Kennedy M, Price RD (26 November 2021). "'It's Coming': NY Declares State of Emergency Ahead of Potential Omicron Spike". NBC New York. Archived from the original on 26 November 2021. Retrieved 27 November 2021.
  111. ^ "Switzerland announces new restrictions for Israelis after the discovery of Omicron". Globally 24. Archived from the original on 27 November 2021. Retrieved 27 November 2021.
  112. ^ Winning A, Cocks T (26 November 2021). "South Africa says travel bans over new variant unjustified". Reuters. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  113. ^ Zwi A (28 November 2021). "Travel bans aren't the answer to stopping new COVID variant Omicron". The Conversation. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  114. ^ "EXCLUSIVE South Africa delays COVID vaccine deliveries as inoculations slow". Reuters. 24 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
  115. ^ Kaitlan Collins and Kate Sullivan (29 November 2021). "Biden says new Omicron variant is 'cause for concern, not a cause for panic'". CNN. Archived from the original on 2 December 2021. Retrieved 1 December 2021.
  116. ^ "New COVID-19 restrictions in effect for parts of Canada; some productions cancelled". CTVNews. 20 December 2021. Archived from the original on 20 December 2021. Retrieved 20 December 2021.
  117. ^ "B.C. enacts social gathering and event capacity limits as Omicron variant spreads". Global News. Archived from the original on 19 December 2021. Retrieved 18 December 2021.
  118. ^ "B.C. limits indoor gatherings, cancels New Year's Eve events as Omicron picks up speed". CBC News. 17 December 2021. Archived from the original on 20 December 2021. Retrieved 17 December 2021.
  119. ^ "Quebec shutting down schools, bars, gyms tonight as COVID-19 cases soar". CTV News Montreal. 20 December 2021. Archived from the original on 20 December 2021. Retrieved 20 December 2021.
  120. ^ Meijer BH, van den Berg S (18 December 2021). "Netherlands to go into strict Christmas lockdown". Reuters. Archived from the original on 2 January 2022. Retrieved 2 January 2022.
  121. ^ "As Omicron threatens a global surge, some countries shorten COVID-19 booster timelines". Reuters. 20 December 2022. Archived from the original on 15 January 2022. Retrieved 15 January 2022.
  122. ^ Gregg A (26 November 2021). "Dow plunges more than 900 points as new coronavirus variant sends global markets reeling". Washington Post. Archived from the original on 26 November 2021. Retrieved 26 November 2021.
  123. ^ "'Omicron' cryptocurrency soars on new variant". www.msn.com. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  124. ^ Davies P (26 November 2021). "Bitcoin's price has slumped after a new COVID variant was found. Why?". euronews. Archived from the original on 27 November 2021. Retrieved 27 November 2021.
  125. ^ "South African markets sink on new Covid-19 variant". Moneyweb. 26 November 2021. Archived from the original on 27 November 2021. Retrieved 29 November 2021.
  126. ^ "Rand tanks as UK red lists South Africa again amid new Covid variant". Archived from the original on 26 November 2021. Retrieved 29 November 2021.
  127. ^ "New variant sees Rand plummet | eNCA". enca.com. Archived from the original on 26 November 2021. Retrieved 29 November 2021.
  128. ^ "Omicron raises uncertainty around inflation, says Powell". BBC News. 2 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021.
  129. ^ "Selection analysis identifies significant mutational changes in Omicron that are likely to influence both antibody neutralization and Spike function (Part 1 of 2)". 5 December 2021. Archived from the original on 17 November 2023. Retrieved 1 December 2023.
  130. ^ Cella, Eleonora; Benedetti, Francesca; Fabris, Silvia; Borsetti, Alessandra; Pezzuto, Aldo; Ciotti, Marco; Pascarella, Stefano; Ceccarelli, Giancarlo; Zella, Davide; Ciccozzi, Massimo; Giovanetti, Marta (2021). "SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview". Chemotherapy. 66 (1–2): 3–7. doi:10.1159/000515340. PMC 8089399. PMID 33735881. Archived from the original on 29 October 2023. Retrieved 1 December 2023.
  131. ^ Khandia R, Singhal S, Alqahtani T, Kamal MA, El-Shall NA, Nainu F, et al. (June 2022). "Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic". Environmental Research. 209: 112816. Bibcode:2022ER....20912816K. doi:10.1016/j.envres.2022.112816. PMC 8798788. PMID 35093310.
  132. ^ Hong Q, Han W, Li J, Xu S, Wang Y, Xu C, et al. (April 2022). "Molecular basis of receptor binding and antibody neutralization of Omicron". Nature. 604 (7906): 546–552. Bibcode:2022Natur.604..546H. doi:10.1038/s41586-022-04581-9. PMID 35228716. S2CID 247167987.
  133. ^ Mileto D, Micheli V, Fenizia C, Cutrera M, Gagliardi G, Mancon A, et al. (December 2022). "Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees' sera: a preliminary evaluation". Emerging Microbes & Infections. 11 (1): 790–792. doi:10.1080/22221751.2022.2045878. PMC 8920392. PMID 35196967.
  134. ^ Zhang L, Mann M, Syed ZA, Reynolds HM, Tian E, Samara NL, et al. (November 2021). "Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation". Proceedings of the National Academy of Sciences of the United States of America. 118 (47): e2109905118. Bibcode:2021PNAS..11809905Z. doi:10.1073/pnas.2109905118. PMC 8617502. PMID 34732583. S2CID 242937417.
  135. ^ Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (April 2020). "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein". Cell. 181 (2): 281–292.e6. doi:10.1016/j.cell.2020.02.058. PMC 7102599. PMID 32155444.
  136. ^ Karthik Gangavarapu; Alaa Abdel Latif; Julia Mullen; Manar Alkuzweny; Emory Hufbauer; Ginger Tsueng; Emily Haag; Mark Zeller; Christine M. Aceves; Karina Zaiets; Marco Cano; Jerry Zhou; Zhongchao Qian; Rachel Sattler; Nathaniel L Matteson; Joshua I. Levy; Raphael TC Lee; Lucas Freitas; Sebastian Maurer-Stroh; GISAID core and curation team; Marc A. Suchard; Chunlei Wu; Andrew I. Su; Kristian G. Andersen; Laura D. Hughes; Center for Viral Systems Biology (18 August 2022). "Lineage Comparison". Outbreak.info. Archived from the original on 24 June 2021. Retrieved 24 August 2022.
  137. ^ Karthik Gangavarapu; Alaa Abdel Latif; Julia Mullen; Manar Alkuzweny; Emory Hufbauer; Ginger Tsueng; Emily Haag; Mark Zeller; Christine M. Aceves; Karina Zaiets; Marco Cano; Jerry Zhou; Zhongchao Qian; Rachel Sattler; Nathaniel L Matteson; Joshua I. Levy; Raphael TC Lee; Lucas Freitas; Sebastian Maurer-Stroh; GISAID core and curation team; Marc A. Suchard; Chunlei Wu; Andrew I. Su; Kristian G. Andersen; Laura D. Hughes; Center for Viral Systems Biology (19 August 2022). "Omicron Variant Report". Outbreak.info. Archived from the original on 20 August 2022. Retrieved 24 August 2022.
  138. ^ Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S, et al. (June 2022). "Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3". The Lancet. Infectious Diseases. 22 (6): 766–767. doi:10.1016/S1473-3099(22)00224-9. PMC 9005119. PMID 35427493.
  139. ^ Mohapatra RK, Kandi V, Sarangi AK, Verma S, Tuli HS, Chakraborty S, et al. (July 2022). "The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic - Correspondence". International Journal of Surgery. 103: 106698. doi:10.1016/j.ijsu.2022.106698. PMC 9176102. PMID 35690362.
  140. ^ a b McGregor G (21 January 2022). "What is 'stealth Omicron'? The rise of the subvariant is alarming some scientists who say it needs its own Greek letter". Fortune. Archived from the original on 23 January 2022. Retrieved 23 January 2022.
  141. ^ Vauhkonen H, Nguyen PT, Kant R, Plyusnin I, Erdin M, Kurkela S, et al. (June 2022). "Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021". Emerging Infectious Diseases. 28 (6): 1229–1232. doi:10.3201/eid2806.220515. PMC 9155872. PMID 35378057.
  142. ^ Rahimi F, Talebi Bezmin Abadi A (March 2022). "The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic". International Journal of Surgery. 99: 106261. doi:10.1016/j.ijsu.2022.106261. PMC 8837492. PMID 35167986.
  143. ^ "SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 29" (PDF). gov.uk. UK Health Security Agency. 26 November 2021. p. 18. Archived (PDF) from the original on 27 November 2021. Retrieved 10 December 2021.
  144. ^ "BA.2 Lineage Report, India". outbreak.info (Scripps Research). 4 February 2022. Archived from the original on 5 February 2022. Retrieved 5 February 2022.
  145. ^ Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J, Uriu K, Tsuda M, Zahradnik J, Shirakawa K, Suzuki R, et al. (9 June 2022). "Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike". Cell. 185 (12): 2103–2115. bioRxiv 10.1101/2022.02.14.480335v1. doi:10.1016/j.cell.2022.04.035. PMC 9057982. PMID 35568035. S2CID 246905491.
  146. ^ Kunkalikar, Bhavana (31 October 2022). "SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron". News-Medical.net. Archived from the original on 6 November 2022. Retrieved 6 November 2022.
  147. ^ a b "BA.2 Lineage Report". outbreak.info (Scripps Research). 21 January 2022. Archived from the original on 13 December 2021. Retrieved 21 January 2022.
  148. ^ "COVID-19 Weekly Epidemiological Update, Edition 77" (PDF). World Health Organization. 1 February 2022. Archived (PDF) from the original on 3 February 2022. Retrieved 2 February 2022.
  149. ^ a b "COVID-19 Weekly Epidemiological Update, Edition 82". World Health Organization. 8 March 2022. Archived from the original on 13 March 2022. Retrieved 12 March 2022.
  150. ^ "COVID-19 Weekly Epidemiological Update, Edition 84". World Health Organization. 22 March 2022. Archived from the original on 26 March 2022. Retrieved 25 March 2022.
  151. ^ Keating D, Dong M, Shin Y (22 March 2022). "How fast omicron's BA.2 variant is spreading around the world". Washington Post. Archived from the original on 23 March 2022. Retrieved 24 March 2022.
  152. ^ "COVID-19 Weekly Epidemiological Update, Edition 80". World Health Organization. 22 February 2022. Archived from the original on 10 March 2022. Retrieved 12 March 2022.
  153. ^ a b "Variant Proportions". Centers for Disease Control and Prevention. 28 March 2020. Archived from the original on 24 August 2020. Retrieved 12 March 2022.
  154. ^ Carassio J (7 February 2022). "BA.1.1, un nouveau sous-variant d'Omicron déjà très répandu en France". Le Progrès. Archived from the original on 12 March 2022. Retrieved 12 March 2022.
  155. ^ "BA.1.1 Lineage Report, United States, France and Japan". outbreak.info (Scripps Research). 12 March 2022. Archived from the original on 14 March 2022. Retrieved 12 March 2022.
  156. ^ Yengkhom S (11 January 2022). "BA.2 'stealth' variant makes up 80% of Kolkata's Omicron infections". The Times of India. Archived from the original on 16 January 2022. Retrieved 17 January 2022.
  157. ^ "Omicron 'sub-lineage' BA.2 designated as COVID variant under investigation, says UKHSA". Sky News. 21 January 2022. Archived from the original on 21 January 2022. Retrieved 21 January 2022.
  158. ^ "SARS-CoV-2 Sequencing Update 14 January 2022" (PDF). Network for Genomic Surveillance in South Africa. 14 January 2022. Archived (PDF) from the original on 17 January 2022. Retrieved 17 January 2022.
  159. ^ "Omicron sub-variant BA.2 'under investigation' by UK health officials". The Independent. 23 January 2022. Archived from the original on 23 January 2022. Retrieved 23 January 2022.
  160. ^ Österman H (11 January 2022). "Undergrupp av omikron ökar: "Kan vara ännu mer smittsam"" (in Swedish). Aftonbladet. Archived from the original on 11 January 2022. Retrieved 17 January 2022.
  161. ^ a b "SARS-CoV-2の変異株B.1.1.529系統(オミクロン株)について(第6報)" (in Japanese). National Institute of Infectious Diseases (Japan). 14 January 2022. Archived from the original on 20 January 2022. Retrieved 24 January 2022.
  162. ^ "新型コロナウイルス感染症(変異株)の患者等の発生について(空港検疫))" (in Japanese). National Institute of Infectious Diseases (Japan). 20 January 2022. Archived from the original on 20 January 2022. Retrieved 24 January 2022.
  163. ^ "新型コロナウイルス感染症(変異株)の患者等の発生について(空港検疫)" (in Japanese). National Institute of Infectious Diseases (Japan). 24 January 2022. Archived from the original on 24 January 2022. Retrieved 24 January 2022.
  164. ^ a b c "Genomic overview of SARS-CoV-2 in Denmark". Danish Covid-19 Genome Consortium. 29 January 2022. Archived from the original on 20 December 2021. Retrieved 29 January 2022.
  165. ^ a b Bernstein L (25 January 2022). "There's a new version of omicron but so far it doesn't appear to be more dangerous". Washington Post. Archived from the original on 25 January 2022. Retrieved 25 January 2022.
  166. ^ "Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States" (PDF). World Health Organization. 21 January 2022. Archived (PDF) from the original on 27 January 2022. Retrieved 24 January 2022.
  167. ^ a b "COVID-19 Ukerapport – uke 2" (PDF) (in Norwegian). Norwegian Institute of Public Health. 19 January 2022. Archived (PDF) from the original on 27 January 2022. Retrieved 25 January 2022.
  168. ^ Winning, Alexander; Shirbon, Estelle (10 February 2022). "Omicron BA.2 sub-variant dominant in S.Africa, says CDC". Reuters. Archived from the original on 12 March 2022. Retrieved 12 March 2022.
  169. ^ "Wöchentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19)" (PDF). Robert Koch Institute. 10 March 2022. Archived (PDF) from the original on 12 March 2022. Retrieved 12 March 2022.
  170. ^ a b "Covid infections rising again across UK - ONS". BBC News. 11 March 2022. Archived from the original on 13 March 2022. Retrieved 12 March 2022.
  171. ^ "BA.2 version of omicron is now dominant coronavirus variant in U.S., CDC says". NBC News. Reuters. 29 March 2022. Archived from the original on 29 March 2022. Retrieved 30 March 2022.
  172. ^ Mohapatra RK, Kandi V, Tuli HS, Chakraborty C, Dhama K (August 2022). "The recombinant variants of SARS-CoV-2: Concerns continues amid COVID-19 pandemic". Journal of Medical Virology. 94 (8): 3506–3508. doi:10.1002/jmv.27780. PMC 9088633. PMID 35419806.
  173. ^ Del Rio C, Malani PN (June 2022). "COVID-19 in 2022-The Beginning of the End or the End of the Beginning?". JAMA. 327 (24): 2389–2390. doi:10.1001/jama.2022.9655. PMID 35622357. S2CID 249096741.
  174. ^ Evon, Dan (14 July 2022). "Why Are People Calling COVID-19 Variant BA.2.75 'Centaurus'?". Snopes.com. Archived from the original on 18 July 2022. Retrieved 15 July 2022.
  175. ^ "Tracking SARS-CoV-2 variants". WHO. Archived from the original on 9 June 2021. Retrieved 15 July 2022.
  176. ^ Sheward, Daniel J; Kim, Changil; Fischbach, Julian; Sato, Kenta; Muschiol, Sandra; Ehling, Roy A; Björkström, Niklas K; Hedestam, Gunilla B Karlsson; Reddy, Sai T; Albert, Jan; Peacock, Thomas P; Murrell, Ben (13 October 2022). "Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies". The Lancet Infectious Diseases. 22 (11): 1538–1540. doi:10.1016/S1473-3099(22)00663-6. PMC 9560757. PMID 36244347.
  177. ^ "Tracking SARS-CoV-2 variants". WHO.int. Archived from the original on 3 February 2023. Retrieved 22 August 2023.
  178. ^ Hamzah, Firdaus (12 October 2022). "CNA Explains: What you need to know about the XBB COVID-19 variant". channelnewsasia.com. Archived from the original on 8 December 2022. Retrieved 13 October 2022.
  179. ^ "Omicron Variant May Cause Another Covid Wave: WHO Chief Scientist". NDTV.com. Archived from the original on 9 February 2023. Retrieved 21 October 2022.
  180. ^ "Update on SARS-CoV-2 variants: ECDC assessment of the XBB.1.5 sub-lineage". European CDC. 9 January 2023. Archived from the original on 18 March 2023. Retrieved 12 January 2023.
  181. ^ "SARS-CoV-2 variants of concern as of 9 January 2023". European CDC. 9 January 2023. Archived from the original on 16 June 2021. Retrieved 12 January 2023.
  182. ^ a b Boyce, Lindsay (12 April 2023). "LibGuides: SARS-CoV-2: SARS-CoV-2 Recombination". Memorial Sloan Kettering Cancer Center. Archived from the original on 15 June 2023. Retrieved 15 April 2023.
  183. ^ Bisset, Victoria (14 April 2023). "What to know about Arcturus, a new coronavirus subvariant the WHO is tracking". Washington Post. Archived from the original on 2 May 2023. Retrieved 15 April 2023.
  184. ^ O'Mary, Lisa (11 April 2023). "New COVID Variant on WHO's Radar Causing Itchy Eyes in Kids". WebMD. Archived from the original on 10 May 2023. Retrieved 16 April 2023.
  185. ^ Johnson, Arianna. "What We Know About 'Eris' Covid Variant EG.5: The Dominant Strain Driving An Uptick In Cases". Forbes. Archived from the original on 23 August 2023. Retrieved 11 August 2023.
  186. ^ "cov-lineages.org". Archived from the original on 27 March 2022. Retrieved 11 August 2023.
  187. ^ Mundasad, Smitha (10 August 2023). "What we know about the Covid variant EG.5 dubbed 'Eris'". BBC News. BBC. Archived from the original on 18 September 2023. Retrieved 10 August 2023.
  188. ^ "EG.5 Initial Risk Evaluation, 9 August 2023" (PDF). World Health Organization. 9 August 2023. Archived (PDF) from the original on 7 December 2023. Retrieved 11 August 2023.
  189. ^ "COVID Data Tracker". 28 March 2020. Archived from the original on 24 August 2020. Retrieved 12 March 2022.
  190. ^ [1] Archived 21 February 2024 at the Wayback Machine What to Know About the HV.1 Variant| — Experts are taking a different approach to new COVID variants these days, researcher says|by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today October 18, 2023
  191. ^ Smith-Schoenwalder, Cecelia (13 August 2023). "WHO, CDC Tracking New COVID-19 Variant BA.2.86". USNews.com. Archived from the original on 18 August 2023. Retrieved 19 August 2023.
  192. ^ "Risk assessment for SARS-CoV-2 variant V-23AUG-01 (or BA.2.86)". UK Health Security Agency. 18 August 2023. Archived from the original on 29 August 2023. Retrieved 30 August 2023.
  193. ^ "WHO monitoring 2 more Omicron sub-variants known as BA.4 and BA.5". Canadian Broadcasting Corporation. 11 April 2022. Archived from the original on 13 April 2022. Retrieved 13 April 2022.
  194. ^ @Tuliodna (11 April 2022). "New Omicron BA.4 & BA.5 detected in South Africa, Botswana, Belgium, Germany, Denmark, and U.K. Early indications that these new sublineages are increasing as a share of genomically confirmed cases in SA" (Tweet) – via Twitter.
  195. ^ Newsroom, Medriva (13 May 2022). "BREAKING: ECDC upgrades Omicron Sublineages BA.4 and BA. 5 to Variants of Concern from Variants of Interest, making it the first public health authority". Medriva. Archived from the original on 14 May 2022. Retrieved 13 May 2022.
  196. ^ O'Regan, Eilish (13 May 2022). "Ireland and Europe at risk of new Covid surge as two new variants of concern declared". independent. Archived from the original on 22 August 2023. Retrieved 13 May 2022.
  197. ^ Davis, Nicola (20 May 2022). "Two types of Omicron classified as Covid variants of concern in UK". the Guardian. Archived from the original on 10 June 2022. Retrieved 14 June 2022.
  198. ^ "Variant BA.5: après le Portugal, les autres pays européens". Sciences et Avenir (in French). 25 May 2022. Archived from the original on 26 May 2022. Retrieved 25 May 2022.
  199. ^ Gilchrist, Karen (24 June 2022). "UK Covid cases surge following Queen's Jubilee celebrations, new variants become dominant". CNBC. Archived from the original on 28 June 2022. Retrieved 24 June 2022.
  200. ^ "Omikron-Subtyp BA.5 herrscht jetzt in Deutschland vor". www.saechsische.de (in German). Archived from the original on 24 June 2022. Retrieved 24 June 2022.
  201. ^ "RKI - Coronavirus SARS-CoV-2 - Wochenbericht vom 23.6.2022" (PDF). www.rki.de. Archived (PDF) from the original on 23 June 2022. Retrieved 25 June 2022.
  202. ^ "BA.5 becomes dominant COVID-19 variant in Germany". The Star. Archived from the original on 24 June 2022. Retrieved 25 June 2022.
  203. ^ "Omicron sub-variants BA.4, BA.5 make up more than 50% of U.S. COVID cases - CDC". Reuters. 28 June 2022. Archived from the original on 28 June 2022. Retrieved 28 June 2022.
  204. ^ Hassan, Adeel (28 June 2022). "The Omicron subvariants BA.4 and BA.5 have together become dominant in the U.S., the C.D.C. estimates". The New York Times. ISSN 0362-4331. Archived from the original on 29 June 2022. Retrieved 28 June 2022.
  205. ^ SPF. "COVID-19: point épidémiologique du 30 juin 2022". www.santepubliquefrance.fr (in French). Archived from the original on 10 July 2022. Retrieved 1 July 2022.
  206. ^ "Variant Covid BA.5: majoritaire en France, quels symptômes?". sante.journaldesfemmes.fr (in French). Archived from the original on 9 July 2022. Retrieved 1 July 2022.
  207. ^ "BA.5.2.1 Lineage Report". Outbreak.info. Archived from the original on 13 July 2022. Retrieved 29 July 2022.
  208. ^ "Shanghai identifies new COVID Omicron subvariant". Reuters. 10 July 2022. Archived from the original on 30 July 2022. Retrieved 29 July 2022.
  209. ^ "SARS-CoV-2 Genomic Surveillance in Ontario, July 22, 2022" (PDF). Public Health Ontario. Archived (PDF) from the original on 19 July 2021. Retrieved 29 July 2022.
  210. ^ "Regeneron COVID-19 Dashboard". Regeneron. Archived from the original on 30 July 2022. Retrieved 29 July 2022.
  211. ^ "COVID-19: Summary data about travellers, testing and compliance". Government of Canada. 14 May 2021. Archived from the original on 4 August 2022. Retrieved 29 July 2022.
  212. ^ "Covid-19 Variant BF.7 Symptoms, Precautions, Transmission". 23 December 2022. Archived from the original on 30 December 2022. Retrieved 25 December 2022.
  213. ^ "Verbreitet sich rasant: Eine der "besorgniserregendsten Varianten": So gefährlich ist BQ.1.1". FOCUS online (in German). 20 October 2022. Archived from the original on 31 October 2022. Retrieved 31 October 2022.
  214. ^ Danner, Chas (21 October 2022). "What We Know About the New and Rising COVID Variants". Intelligencer. Vox Media, LLC. nymag.com. Archived from the original on 1 November 2022. Retrieved 1 November 2022.
  215. ^ Braun, Anja (27 October 2022). "Neue Corona-Subvariante BQ.1.1 - "Höllenhund"-Virusvariante ist in Deutschland angekommen". SWR Wissen (in German). Südwestrundfunk. Archived from the original on 31 October 2022. Retrieved 31 October 2022.
  216. ^ "A new Omicron variant, BQ.1.1, is spreading throughout France". Le Monde.fr. 25 October 2022. Archived from the original on 3 January 2023. Retrieved 20 November 2022.
  217. ^ sante publique france. "COVID-19: epidemiological update. Weekly report. Week 45. 17 November 2022" (in French). Archived from the original on 28 November 2022. Retrieved 20 November 2022.
  218. ^ O'Mary, Lisa (14 November 2022). "BQ.1 and BQ.1.1 Become New Dominant COVID Subvariants". Medscape. Archived from the original on 25 November 2022. Retrieved 16 November 2022.
  219. ^ Rozsa M, Karlis N (28 January 2022). "Omicron variant of COVID-19 may be the most contagious virus to ever exist". Salon. Archived from the original on 28 January 2022. Retrieved 30 January 2022.
  220. ^ "LIVE – Covid: 'Staggering' Omicron case numbers expected – top health official". BBC News. 15 December 2021. Archived from the original on 22 December 2021. Retrieved 15 December 2021. See entry for 10:05
  221. ^ Wang R, Chen J, Wei GW (December 2021). "Mechanisms of SARS-CoV-2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America" (PDF). The Journal of Physical Chemistry Letters. 12 (49): 11850–11857. doi:10.1021/acs.jpclett.1c03380. PMC 8672435. PMID 34873910. Archived (PDF) from the original on 18 December 2021. Retrieved 27 January 2022.
  222. ^ "Study findings suggest spread of Omicron can be ascribed to immune evasiveness rather than an increase in transmissibility". News-Medical.net. 5 January 2022. Archived from the original on 21 January 2022. Retrieved 17 January 2022.
  223. ^ Lyngse FP, Mortensen LH, Denwood MJ, Christiansen LE, Møller CH, Skov RL, et al. (27 December 2021). "SARS-CoV-2 Omicron VOC Transmission in Danish Households". medRxiv 10.1101/2021.12.27.21268278v1.
  224. ^ Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. (February 2022). "Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies". Nature. 602 (7898): 657–663. doi:10.1038/d41586-021-03796-6. PMC 8866119. PMID 35016194. S2CID 245455422.
  225. ^ Wilhelm A, Widera M, Grikscheit K, Toptan T, Schenk B, Pallas C, et al. (8 December 2021). "Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies". medRxiv 10.1101/2021.12.07.21267432.
  226. ^ Liu L, Iketani S, Guo Y, Chan JF, Wang M, Liu L, et al. (February 2022). "Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2". Nature. 602 (7898): 676–681. doi:10.1038/d41586-021-03826-3. PMID 35016198. S2CID 245462866.
  227. ^ Roessler A, Riepler L, Bante D, von Laer D, Kimpel J (11 December 2021). "SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals". medRxiv 10.1101/2021.12.08.21267491.
  228. ^ "Omicron Variant: What You Need to Know". Centers for Disease Control and Prevention. 20 December 2021. Archived from the original on 27 January 2022. Retrieved 27 January 2022.
  229. ^ a b David Leonhardt (5 January 2022). "Omicron Is Milder". The New York Times. Archived from the original on 6 January 2022. Retrieved 7 January 2022. A few weeks ago, many experts and journalists were warning that the initial evidence from South Africa — suggesting that Omicron was milder than other variants — might turn out to be a mirage. It has turned out to be real.
  230. ^ Mohsin M, Mahmud S (May 2022). "Omicron SARS-CoV-2 variant of concern: A review on its transmissibility, immune evasion, reinfection, and severity". Medicine. 101 (19): e29165. doi:10.1097/MD.0000000000029165. PMC 9276130. PMID 35583528. S2CID 248858919.
  231. ^ Bobrovitz, Niklas; Ware, Harriet; Ma, Xiaomeng; Li, Zihan; Hosseini, Reza; Cao, Christian; Selemon, Anabel; Whelan, Mairead; Premji, Zahra; Issa, Hanane; Cheng, Brianna; Abu Raddad, Laith J; Buckeridge, David L; Van Kerkhove, Maria D; Piechotta, Vanessa; Higdon, Melissa M; Wilder-Smith, Annelies; Bergeri, Isabel; Feikin, Daniel R; Arora, Rahul K; Patel, Minal K; Subissi, Lorenzo (May 2023). "Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression". The Lancet Infectious Diseases. 23 (5): 556–567. doi:10.1016/S1473-3099(22)00801-5. PMC 10014083. PMID 36681084.
  232. ^ "Why Omicron-infected white-tailed deer pose an especially big risk to humans". Fortune. Archived from the original on 13 February 2022. Retrieved 13 February 2022.
  233. ^ "Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests". Reuters. 24 January 2022. Archived from the original on 28 January 2022. Retrieved 28 January 2022.
  234. ^ Hirose R, Itoh Y, Ikegaya H, Miyazaki H, Watanabe N, Yoshida T, et al. (19 January 2022). "Differences in environmental stability among SARS-CoV-2 variants of concern: Omicron has higher stability". bioRxiv 10.1101/2022.01.18.476607.
  235. ^ Zhou, Hao; Møhlenberg, Michelle; Thakor, Jigarji C.; Tuli, Hardeep Singh; Wang, Pengfei; Assaraf, Yehuda G.; Dhama, Kuldeep; Jiang, Shibo (21 September 2022). "Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant". Clinical Microbiology Reviews. 35 (3): e00014–22. doi:10.1128/cmr.00014-22. PMC 9491202. PMID 35862736.
  236. ^ "Pfizer And BioNTech Provide Update On Omicron Variant" (Press release). New York City and Mainz: Pfizer. 8 December 2021. Archived from the original on 21 December 2021. Retrieved 8 December 2021.
  237. ^ SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 31 (PDF) (Briefing). Public Health England. 10 December 2021. pp. 3–5, 20–22. GOV-10645. Archived (PDF) from the original on 18 December 2021. Retrieved 10 December 2021.
  238. ^ Ferguson N, Ghani A, Hinsley W, Volz E (22 December 2021). Hospitalisation risk for Omicron cases in England (Technical report). WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis. Imperial College London. doi:10.25561/93035. Report 50. Archived (PDF) from the original on 23 December 2021.
  239. ^ "Israeli trial, world's first, finds 4th dose 'not good enough' against Omicron". www.timesofisrael.com. 18 January 2022. Archived from the original on 30 March 2022. Retrieved 11 April 2022.
  240. ^ Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, et al. (COMMIT-KZN Team) (February 2022). "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization". Nature. 602 (7898): 654–656. Bibcode:2022Natur.602..654C. doi:10.1038/s41586-021-04387-1. PMC 8866126. PMID 35016196. S2CID 245879254.
  241. ^ Callaway E (December 2021). "Omicron likely to weaken COVID vaccine protection". Nature. 600 (7889): 367–368. Bibcode:2021Natur.600..367C. doi:10.1038/d41586-021-03672-3. PMID 34880488. S2CID 245007078.
  242. ^ Arbel R, Hammerman A, Sergienko R, Friger M, Peretz A, Netzer D, Yaron S (December 2021). "BNT162b2 Vaccine Booster and Mortality Due to Covid-19". The New England Journal of Medicine. 385 (26): 2413–2420. doi:10.1056/NEJMoa2115624. PMC 8728797. PMID 34879190.
  243. ^ Khoury DS, Steain M, Triccas J, Sigal A, Davenport MP (17 December 2021). "A meta-analysis of Early Results to predict Vaccine efficacy against Omicron". medRxiv 10.1101/2021.12.13.21267748.
  244. ^ Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, et al. (December 2021). "mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant". medRxiv 10.1101/2021.12.14.21267755.
  245. ^ Doria-Rose NA, Shen X, Schmidt SD, O'Dell S, McDanal C, Feng W, et al. (December 2021). "Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization". medRxiv 10.1101/2021.12.15.21267805v2.
  246. ^ Hansen CH, Schelde AB, Moustsen-Helms IR, Emborg HD, Krause TG, Mølbak K, Valentiner-Branth P, et al. (Infectious Disease Preparedness Group at Statens Serum Institute) (23 December 2021). "Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study". medRxiv 10.1101/2021.12.20.21267966.
  247. ^ Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, et al. (December 2021). "Protection against Covid-19 by BNT162b2 Booster across Age Groups". The New England Journal of Medicine. 385 (26): 2421–2430. doi:10.1056/NEJMoa2115926. PMC 8728796. PMID 34879188.
  248. ^ Geddes L (29 November 2021). "What does appearance of Omicron variant mean for the double-vaccinated?". The Guardian. London. Archived from the original on 29 November 2021. Retrieved 29 November 2021.
  249. ^ Omicron: what do we know about the new Covid variant? Archived 5 December 2021 at the Wayback Machine The Guardian
  250. ^ "Boosters increase protection against death from Omicron in over-50s to 95% – UKHSA". The Guardian. 27 January 2022. Archived from the original on 29 January 2022. Retrieved 27 January 2022.
  251. ^ "COVID-19 vaccine surveillance report Week 4" (PDF). UK Health Security Agency. 27 January 2022. Archived (PDF) from the original on 27 January 2022. Retrieved 27 January 2022.
  252. ^ "How soon after catching COVID-19 can you get it again?". ABC News. 2 May 2022. Archived from the original on 9 July 2022. Retrieved 24 June 2022.
  253. ^ Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, et al. (1 May 2022). "Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity". medRxiv 10.1101/2022.04.29.22274477.
  254. ^ Suryawanshi RK, Chen IP, Ma T, Syed AM, Brazer N, Saldhi P, et al. (May 2022). "Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination". Nature. 607 (7918): 351–355. Bibcode:2022Natur.607..351S. doi:10.1038/s41586-022-04865-0. PMC 9279157. PMID 35584773. S2CID 248890159.
  255. ^ "SARS-CoV-2 sequences by variant". Our World in Data. Archived from the original on 1 May 2022. Retrieved 30 June 2022.
  256. ^ Huang, Pien. "How monoclonal antibodies lost the fight with new COVID variants". NPR. Archived from the original on 15 August 2023. Retrieved 15 August 2023.
  257. ^ Shin DH, Smith DM, Choi JY (2022). "SARS-CoV-2 Omicron Variant of Concern: Everything You Wanted to Know about Omicron but Were Afraid to Ask". Yonsei Medical Journal. 63 (11): 977–983. doi:10.3349/ymj.2022.0383. PMC 9629902. PMID 36303305.
  258. ^ "COVID-19 Vaccine Boosters". U.S. Food and Drug Administration (FDA). 27 September 2022. Archived from the original on 8 October 2022. Retrieved 8 October 2022.
  259. ^ "Moderna COVID-19 Vaccines". U.S. Food and Drug Administration. 7 October 2022. Archived from the original on 7 October 2022. Retrieved 8 October 2022.
  260. ^ "Pfizer-BioNTech COVID-19 Vaccines". U.S. Food and Drug Administration. 3 October 2022. Archived from the original on 8 October 2022. Retrieved 8 October 2022.
  261. ^ "Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2023". U.S. Food and Drug Administration (FDA). 15 June 2023. Archived from the original on 17 June 2023. Retrieved 16 June 2023. Public Domain This article incorporates text from this source, which is in the public domain.
  262. ^ Recommendation for the 2023-2024 Formula of COVID-19 vaccines in the U.S. (PDF) (Report). U.S. Food and Drug Administration (FDA). 16 June 2023. Archived from the original on 16 June 2023. Retrieved 16 June 2023.
  263. ^ "Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2024". U.S. Food and Drug Administration (FDA). 5 June 2024. Archived from the original on 18 June 2024. Retrieved 19 June 2024. Public Domain This article incorporates text from this source, which is in the public domain.
  264. ^ Geddes, Linda (17 December 2021). "How do the symptoms of Omicron differ from previous COVID-19 variants?". GAVI. Archived from the original on 13 December 2022. Retrieved 13 December 2022.
  265. ^ Quann, Jack (7 July 2022). "Luke O'Neill: Night sweats now a sign of BA.5 COVID variant". Newstalk. Archived from the original on 20 July 2022. Retrieved 10 July 2022.
  266. ^ Bawden, Tom (2 August 2022). "New Covid symptoms: Night sweats emerge as common sign of Omicron BA.5 with 1 in 10 suffering hot flushes". i. Archived from the original on 13 December 2022. Retrieved 13 December 2022.
  267. ^ CDC COVID-19 Response Team (December 2021). "SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021". MMWR. Morbidity and Mortality Weekly Report. 70 (50). Center for Disease Control: 1731–1734. doi:10.15585/mmwr.mm7050e1. PMC 8675659. PMID 34914670. S2CID 245071514. Archived from the original on 20 December 2021. Retrieved 17 December 2021.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  268. ^ Antonelli, Michela; Pujol, Joan Capdevila; Spector, Tim D.; Ourselin, Sebastien; Steves, Claire J. (18 June 2022). "Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2". The Lancet. 399 (10343): 2263–2264. doi:10.1016/S0140-6736(22)00941-2. ISSN 0140-6736. PMC 9212672. PMID 35717982.
  269. ^ Harvard Medical School (6 January 2022). "Coronavirus Resource Center – Harvard Health". Harvard Health Publishing. Archived from the original on 11 January 2022. Retrieved 7 January 2022. Lab studies, animal studies, and epidemiological data all indicate that Omicron may cause less severe disease than previous variants.
  270. ^ "Lung tissue study sheds light on fast Omicron spread". CIDRAP. 15 December 2021. Archived from the original on 16 December 2021. Retrieved 25 December 2021.
  271. ^ Lewnard JA, Hong VX, Patel MM, Kahn R, Lipsitch M, Tartof SY (11 January 2022). "Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California". medRxiv 10.1101/2022.01.11.22269045.
  272. ^ "Some reduction in hospitalisation for Omicron v Delta in England: early analysis". Imperial College London. 22 December 2021. Archived from the original on 22 January 2022. Retrieved 22 January 2022.
  273. ^ a b c Parker C (21 January 2022). "Government scientists monitoring new BA.2 variant of Omicron". Yahoo News. Archived from the original on 21 January 2022. Retrieved 21 January 2022.
  274. ^ Larsen JA (21 January 2022). "Ny Omikron-variant tager over i Danmark – det ved vi om den" (in Danish). TV2. Archived from the original on 22 January 2022. Retrieved 21 January 2022.
  275. ^ Berger M (28 November 2021). "South Africa, which found the omicron variant first, leads Africa in coronavirus sequencing". Washington Post. Archived from the original on 2 December 2021. Retrieved 2 December 2021.
  276. ^ "Sequencing by country". GISAID. 2 December 2021. Archived from the original on 2 December 2021. Retrieved 2 December 2021.
  277. ^ Geddes L (15 December 2021). "How big is the risk of Omicron in the UK and how do we know?". The Guardian. Archived from the original on 21 December 2021. Retrieved 15 December 2021.
  278. ^ "Only one approved rapid test in Australia explicitly states it detects Omicron". the Guardian. 27 January 2022. Archived from the original on 30 January 2022. Retrieved 30 January 2022.
  279. ^ "Post-market review of antigen and rapid antigen tests". Archived from the original on 15 August 2023. Retrieved 15 August 2023.
  280. ^ "STATEMENT MANY RAPID TESTS DETECT OMICRON" (PDF). PEI. 17 August 2022. Archived (PDF) from the original on 16 August 2022. Retrieved 16 August 2022.
  281. ^ "SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests". FDA. 16 December 2021. Archived from the original on 21 December 2021. Retrieved 16 December 2021.
  282. ^ a b "SARS-CoV-2 variants of concern and variants under investigation in England" (PDF). Archived (PDF) from the original on 18 December 2021. Retrieved 10 December 2021.
  283. ^ a b "Variant-PCR-testen (tidl. Delta-PCR-testen)" (in Danish). Statens Serum Institut. 21 December 2021. Archived from the original on 7 February 2021. Retrieved 17 January 2022.
  284. ^ a b Oppdatert, Publisert (12 August 2021). "Statistikk over meldte tilfeller av virusvarianten omikron". Folkehelseinstituttet (in Norwegian). Retrieved 22 December 2021.
  285. ^ "Status på omikron-varianten (B.1.1.529) pr. 05.12.21" [Status of the Omicron variant (B.1.1.529) per 05.12.21] (in Danish). Statens Serum Institut. Archived from the original on 7 December 2021. Retrieved 18 December 2021.
  286. ^ a b Sample I, Walker P (7 December 2021). "Scientists find 'stealth' version of Omicron that may be harder to track". www.theguardian.com. Archived from the original on 7 December 2021. Retrieved 7 December 2021.
  287. ^ "Stealth Omicron: What is The Fast Spreading Omicron BA.2 Sub-Variant That Can Escape RT-PCR Test?". india.com. 23 January 2022. Archived from the original on 23 January 2022. Retrieved 23 January 2022.
  288. ^ Rajeshuni, N (26 January 2022). "Scientists monitoring new omicron subvariant BA.2". ABC News. Archived from the original on 1 February 2022. Retrieved 2 February 2022.
  289. ^ "Delta Variant Report". outbreak.info (Scripps Research). 13 December 2021. Archived from the original on 19 December 2021. Retrieved 13 December 2021.
  290. ^ "BA.1 Lineage Report". outbreak.info (Scripps Research). 19 December 2021. Archived from the original on 16 December 2021. Retrieved 19 December 2021.
  291. ^ Zimmer C, Lyons, PJ (24 February 2022). "Is the BA.2 version of Omicron worse? Here's what you need to know". The New York Times. Archived from the original on 12 March 2022. Retrieved 12 March 2022.
  292. ^ a b "Update on Omicron". World Health Organization. 28 November 2021. Archived from the original on 30 November 2021.
  293. ^ Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, et al. (April 2021). "Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19". The New England Journal of Medicine. 384 (16): 1491–1502. doi:10.1056/NEJMoa2100433. PMC 7953461. PMID 33631065.
  294. ^ Cathcart AL, Havenar-Daughton C, Lempp FA, Ma D, Schmid M, Agostini ML, et al. (2021). "The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2". bioRxiv 10.1101/2021.03.09.434607.
  295. ^ McCallum M, Czudnochowski N, Rosen LE, Zepeda SK, Bowen JE, Dillen JR, et al. (2021). "Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement". bioRxiv 10.1101/2021.12.28.474380.
  296. ^ Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, et al. (December 2021). "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift". bioRxiv. 602 (7898). doi:10.1038/d41586-021-03825-4. PMC 8687478. PMID 34931194.
  297. ^ "March 25, 2022 | Important Update | HHS/ASPR". aspr.hhs.gov. Archived from the original on 27 January 2023. Retrieved 6 April 2022.
  298. ^ Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. (February 2022). "Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies". Nature. 602 (7898): 657–663. doi:10.1038/d41586-021-03796-6. PMC 8866119. PMID 35016194. S2CID 245455422.
  299. ^ "Latest confirmed cases of COVID-19 in South Africa (26 November 2021)". National Institute for Communicable Diseases. 26 November 2021. Archived from the original on 4 December 2021.
  300. ^ "Latest confirmed cases of COVID-19 in South Africa (3 December 2021)". National Institute for Communicable Diseases. 3 December 2021. Archived from the original on 4 December 2021.
  301. ^ see also GIS dashboard Archived 8 September 2021 at the Wayback Machine (statistical data) www.nicd.ac.za
  302. ^ Pulliam JR, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. (January 2021). "SARS-CoV-2 reinfection trends in South Africa: analysis of routine surveillance data". medRxiv 10.1101/2021.11.11.21266068.
  303. ^ "Omicron seems to carry higher Covid reinfection risk, says South Africa". The Guardian. 2 December 2021. Archived from the original on 3 December 2021. Retrieved 3 December 2021.
  304. ^ "'Patience is crucial': Why we won't know for weeks how dangerous Omicron is". www.science.org. Archived from the original on 30 November 2021. Retrieved 30 November 2021.
  305. ^ "Proportion and number of clades by epiweek in South Africa, 2021" (PDF). Network for Genomic Surveillance in South Africa. National Institute for Communicable Diseases. 26 November 2021. Archived (PDF) from the original on 2 December 2021. Retrieved 2 December 2021.
  306. ^ "Omicron becomes dominant variant in South Africa". The Guardian. 2 December 2021. Archived from the original on 2 December 2021. Retrieved 2 December 2021.
  307. ^ "Risk assessment for SARS-CoV-2 variant: Omicron VOC-21NOV-01 (B.1.1.529): 3 December 2021" (PDF). GOV.UK. Archived (PDF) from the original on 4 December 2021. Retrieved 4 December 2021.
  308. ^ McCarthy K, Rachida S, Yousif M, Ndlovu N, Iwu-Jaja C, Howard W, et al. "Wastewater-based epidemiology for SARS-CoV-2 in South Africa" (PDF). National Institute for Communicable Diseases. Archived (PDF) from the original on 9 November 2021. Retrieved 30 November 2021.
  309. ^ "COVID-19: Toddlers make up 10% of hospital cases in South Africa's Omicron epicentre". gulfnews.com. Archived from the original on 2 December 2021. Retrieved 2 December 2021.
  310. ^ "Omicron Spread in South Africa". p. 6. Archived from the original on 4 December 2021. Retrieved 4 December 2021.
  311. ^ Mandavilli A (4 December 2021). "Omicron Variant Spreading Twice as Quickly as Delta in South Africa". The New York Times. ISSN 0362-4331. Archived from the original on 4 December 2021. Retrieved 4 December 2021.
  312. ^ The SARS-CoV-2 variant Omicron: a snapshot of where we are – 08.12.2021, 5 PM CET., 8 December 2021, archived from the original on 21 December 2021, retrieved 10 December 2021
  313. ^ "Prof. Albertsen deliberations". Twitter. Archived from the original on 14 December 2021. Retrieved 11 December 2021.
  314. ^ "SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 33" (PDF). gov.uk. UK Health Security Agency. 23 December 2021. Archived (PDF) from the original on 2 January 2022. Retrieved 15 January 2022.
  315. ^ Covid-19 Rapport om omikronvarianten [Status of the SARS-CoV-2 variant Omicron in Denmark] (PDF) (Report) (in Danish). Statens Serum Institut. 20 December 2021. Archived (PDF) from the original on 21 December 2021. Retrieved 21 December 2021.
  316. ^ Ekspertrapport den 17. december 2021 – Scenarier for smittetal og nyindlæggelser med omikronvarianten [Expert report 17 December 2021 – Scenarios for infection numbers and new hospitalizations with the Omicron-variant] (PDF) (Report) (in Danish). Statens Serum Institut. 18 December 2021. Archived (PDF) from the original on 19 December 2021. Retrieved 18 December 2021.
  317. ^ "Variant-PCR svar fra 27. nov. og frem, Testcenter Danmark" (in Danish). Archived from the original on 27 December 2021. Retrieved 27 December 2021.
  318. ^ "Schweiz sitrep". Twitter. 10 December 2021. Archived from the original on 12 December 2021. Retrieved 10 December 2021.
  319. ^ "RKI – Coronavirus SARS-CoV-2 – Wochenbericht vom 13.1.2022" (PDF). www.rki.de. Archived (PDF) from the original on 24 January 2022. Retrieved 13 January 2022.
  320. ^ "Omicron in Scotland – evidence paper". www.gov.scot. Archived from the original on 20 December 2021. Retrieved 11 December 2021.
  321. ^ Wenseleers T (22 December 2021), tomwenseleers/newcovid_belgium, archived from the original on 22 December 2021, retrieved 22 December 2021
  322. ^ "Ontario Dashboard". Ontario COVID-19 Science Advisory Table. Archived from the original on 17 March 2021. Retrieved 12 December 2021.
  323. ^ "COVID Data Tracker". Centers for Disease Control and Prevention. 28 March 2020. Archived from the original on 22 May 2021. Retrieved 21 December 2021.
  324. ^ "Portugal says Omicron dominant, infections rising". NewsNine. 25 December 2021. Archived from the original on 28 December 2021. Retrieved 28 December 2021.
  325. ^ Wenseleers T (20 December 2021), tomwenseleers/newcovid_belgium, archived from the original on 22 December 2021, retrieved 21 December 2021
  326. ^ "Variants of the coronavirus SARS-CoV-2 in the Netherlands". National Institute for Public Health and the Environment. Archived from the original on 11 January 2022. Retrieved 14 January 2022.
  327. ^ "COVID: Omicron accountts for 28% of cases in Italy, will soon be dominant". ANSA.en. 23 December 2021. Archived from the original on 24 December 2021. Retrieved 28 December 2021.
  328. ^ Oppdatert P (8 December 2021). "Statistikk over meldte tilfeller av virusvarianten omikron" (in Norwegian). Folkehelseinstituttet. Archived from the original on 28 December 2021. Retrieved 29 December 2021.
  329. ^ "Covid-19: Omicron is now the dominant variant in France". France24. 31 December 2021. Archived from the original on 3 January 2022. Retrieved 31 December 2021.
  330. ^ "Omicron is now the dominant variant in France". CNN. 31 December 2021. Archived from the original on 31 December 2021. Retrieved 31 December 2021.
  331. ^ Maxmen A (December 2021). "Omicron blindspots: why it's hard to track coronavirus variants". Nature. 600 (7890): 579. Bibcode:2021Natur.600..579M. doi:10.1038/d41586-021-03698-7. PMID 34916668. S2CID 245262198.
  332. ^ "SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing 38" (PDF). assets.publishing.service.gov.uk. Retrieved 3 January 2022.
  333. ^ "The puzzle of America's record Covid hospital rate". BBC News. 13 January 2022. Archived from the original on 14 January 2022. Retrieved 14 January 2022.
  334. ^ "Cov-Lineages". cov-lineages.org. Retrieved 15 January 2022. Updated frequently.
  335. ^ "Tracking of Variants". GISAID. Archived from the original on 23 June 2021. Retrieved 12 January 2022. Updated frequently.
  336. ^ a b c d "Newsnodes - Omicron tracker". newsnodes.com. Retrieved 24 December 2021.
  337. ^ a b "UK Health Security Agency Omicron daily overview: 31 December 2021" (PDF).
  338. ^ a b "Wochenberichte zu COVID-19" (in German). Robert Koch Institute. 16 December 2021. Retrieved 19 December 2021.
  339. ^ a b c d e f g h "Omicron in Europe: Where has the new COVID variant been detected?". euronews. 13 December 2021. Retrieved 20 December 2021.
  340. ^ "SARS-CoV-2-Varianten in Österreich". AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit (in German). Retrieved 20 December 2021.
  341. ^ "Omikron (B.1.1.529)" [Omicron (B.1.1.529)] (in Danish). Statens Serum Institut. Retrieved 21 December 2021.
  342. ^ "Coronavirus: chiffres clés et évolution de la COVID-19 en France et dans le Monde". www.santepubliquefrance.fr (in French). Retrieved 19 December 2021.
  343. ^ "Tracking variants of the novel coronavirus in Canada". CTV News. 4 February 2021. Retrieved 29 July 2022.
  344. ^ "新型コロナウイルス ゲノム解析による検疫の系統別検出状況(2022年7月27日時点)". www.mhlw.go.jp (in Japanese).
  345. ^ India, COVID19. "INDIA WE WILL FIGHT IT TOGETHER". COVID19 India. Retrieved 30 December 2021.{{cite web}}: CS1 maint: numeric names: authors list (link)
  346. ^ "Omicron Cases in India | Coronavirus Cases in India". NDTV.com. 17 January 2022. Retrieved 22 August 2023.
  347. ^ "Variants of concern". CDGN. Retrieved 7 January 2022.
  348. ^ "Country Has 5,397 Omicron Cases". สำนักข่าวไทย อสมท (in Thai). 10 January 2022. Retrieved 10 January 2022.
  349. ^ "Indonesia Laporkan 3.779 Kasus Omicron". CNNIndonesia.com (in Indonesian). 8 February 2022. Retrieved 8 February 2022.
  350. ^ "Singapore reports 24 confirmed Omicron cases as at Thursday". www.thesundaily.my. Retrieved 18 December 2021.
  351. ^ Auto, Hermes (22 December 2021). "More Omicron cases picked up in Singapore; community spread a matter of time: MOH | The Straits Times". www.straitstimes.com. Retrieved 22 December 2021.
  352. ^ Acharya, Ashutosh (29 December 2021). "Omicron most transmissible COVID-19 variant but not threatening Singapore: Experts". The Federal. Retrieved 29 December 2021.
  353. ^ "MOH | News Highlights". www.moh.gov.sg. Retrieved 1 January 2022.
  354. ^ "Tänahommikuse seisuga on haiglas 274 koroonaviirusega nakatunud patsienti" [As of this morning, the hospital has 274 patients infected with the coronavirus]. terviseamet.ee (in Estonian). 13 December 2021. Retrieved 13 December 2021. Eestis on tuvastatud kokku 26 koroonapositiivset, kelle puhul viitab genotüpiseerimine omikron tüvele, nendest kuus on kinnitatud sekveneerimise käigus... A total of 26 corona-positive cases have been identified in Estonia, in which case genotyping indicates an omicron strain, six of which have been confirmed during sequencing...
  355. ^ "Tänahommikuse seisuga on haiglas 220 koroonaviirusega nakatunud patsienti | Terviseamet". www.terviseamet.ee (in Estonian). Retrieved 22 December 2021.
  356. ^ "Tänahommikuse seisuga on haiglas 231 koroonaviirusega nakatunud patsienti | Terviseamet". www.terviseamet.ee (in Estonian). Retrieved 31 December 2021.
  357. ^ a b @IsraelMOH (25 December 2021). "היום, 25/12/2021 זוהו 591 מאומתים חדשים" [Today, 25/12/2021, 591 new verified people were identified] (Tweet) (in Hebrew) – via Twitter.
  358. ^ Schneider, Tal. "In Israel's first suspected Omicron death, vaccinated woman succumbs to virus". Times of Israel. Retrieved 29 December 2021.
  359. ^ "Lineage B.1.1.529". cov-lineages.org. Cov-Lineages. Retrieved 19 December 2021.
  360. ^ "Omicron variant more resistant to vaccine but causes less severe covid, major South African study concludes". Washington Post. ISSN 0190-8286. Retrieved 16 December 2021. Later information provided by a Discovery Health spokeswoman put the number of total cases at 78,173, of which 19,070 tests were positive during the "omicron period" from Nov. 15 to Dec. 7.
  361. ^ 고병준 (3 January 2022). "(2nd LD) Daily virus cases stay below 4,000 for 2nd straight day amid tighter antivirus curbs". Yonhap News Agency. Retrieved 4 January 2022.
  362. ^ a b c d e f g h "Epidemiological update: Omicron variant of concern (VOC) – data as of 16 December 2021 (12:00)". European Centre for Disease Prevention and Control. 16 December 2021. Retrieved 20 December 2021.
  363. ^ "Statistik om SARS-CoV-2 virusvarianter av särskild betydelse — Folkhälsomyndigheten". Public Health Agency of Sweden (in Swedish). Retrieved 5 January 2022.
  364. ^ "COVID-⁠19 Switzerland | Coronavirus | Dashboard". covid19.admin.ch. Retrieved 29 December 2021.
  365. ^ "Ómicron: the Ministry of Health confirmed the first case in Argentina". MRT. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 6 December 2021.
  366. ^ "Córdoba confirmó 454 casos de la variante Ómicron de coronavirus" [Córdoba confirmed 454 cases of the Omicron variant of coronavirus] (in Spanish). Télam. 19 December 2021. Retrieved 19 December 2021.
  367. ^ "Hay más de 80 casos posibles de Ómicron en Argentina" [There are more than 80 possible cases of Ómicron in Argentina] (in Spanish). 13 December 2021. Retrieved 13 December 2021.
  368. ^ a b "Table 1. Confirmed cases of SARS-CoV-2 Omicron VOC reported by public sources, as of 10 December 2021 (12:00)". ecdc.europa.eu. European Centre for Disease Prevention and Control (ECDC). 10 December 2021. Retrieved 16 December 2021.
  369. ^ "Omikronvariant B.1.1.529". National Institute for Public Health and the Environment. Retrieved 15 December 2021.
  370. ^ "Summary of COVID-19 virus variants in Ireland – HPSC". HSE Health Protection Surveillance Centre (HPSC). 13 July 2022. p. 7. Retrieved 15 July 2022.
  371. ^ "Travel restrictions tightened as Rock confirms 24 Omicron cases". 17 December 2021. Retrieved 20 December 2021.
  372. ^ "Kári spáir omíkron-bylgju í janúar". ruv.is (in Icelandic). 18 December 2021. Retrieved 19 December 2021.
  373. ^ "Covid-19: sulla piattaforma ICoGen 84 sequenze della variante Omicron" [Covid-19: 84 sequences of the Omicron variant on the ICoGen platform] (in Italian). 18 December 2021. Archived from the original on 20 December 2021. Retrieved 20 December 2021.
  374. ^ "ISP confirmó 30 casos de la nueva variante Ómicron a nivel nacional". CNN Chile (in Spanish). 16 December 2021. Archived from the original on 16 December 2021. Retrieved 19 December 2021.
  375. ^ "Autoridad sanitaria informa 73 casos confirmados con variante Ómicron en Chile". La Tercera. 20 December 2021. Retrieved 21 December 2021.
  376. ^ Ministerio de Salud [@ministeriosalud] (3 January 2022). "'Tenemos 684 casos #ómicron en todo el país. De ellos, 661 corresponden a viajeros, 14 casos positivos con nexo de viajeros y 9 son los casos comunitarios, estos últimos, todos en la región Metropolitana'" ['We have 684 #omicron cases nationwide. Of these, 661 correspond to travelers, 14 positive cases connected to travelers and 9 are community cases, the latter, all in the Metropolitan region.'] (Tweet) (in Spanish). Retrieved 4 January 2022 – via Twitter.
  377. ^ "Portugal tem 38 casos da variante ómicron. Cuidados intensivos com "tendência fortemente crescente"" [Portugal has 38 cases of the omicron variant. Intensive care shows "strongly increasing trend"]. Público. 3 December 2021. Archived from the original on 4 December 2021. Retrieved 4 December 2021.
  378. ^ "Monitorização das linhas vermelhas para a COVID-19" [Monitoring of red lines for COVID-19] (PDF). INSA (in Portuguese). National Health Service of Portugal. 3 December 2021. p. 14. Archived (PDF) from the original on 4 December 2021. Retrieved 7 December 2021.
  379. ^ a b Badri, Souad. "Omicron: 76 cas enregistrés au Maroc dont une personne admise en réanimation". Le Matin (in French). Retrieved 29 December 2021.
  380. ^ "Zimbabwe says country has identified 50 cases of Omicron". Reuters. Johannesburg. 3 December 2021. Archived from the original on 3 December 2021. Retrieved 3 December 2021.
  381. ^ "Ômicron: incidência já é de 31,7% em oito estados do Brasil, mostra levantamento inédito" (in Brazilian Portuguese). Editora Globo S/A. 29 December 2021. Retrieved 31 December 2021.
  382. ^ "THL ja STM: Etelä-Suomessa lähes kaikki tapaukset omikronia". Yle Uutiset (in Finnish). 5 January 2022. Retrieved 6 January 2022.
  383. ^ "53,600 COVID infections diagnosed in 1 week, 140 deaths in 2 weeks". clickittefaq. 13 January 2022. Retrieved 13 January 2022. The total number of cases of the Omicron variant was 523 until Wednesday.
  384. ^ "Cyprus detects first cases of COVID-19 Omicron variant". news.trust.org. Reuters. Retrieved 10 December 2021.
  385. ^ "Coronavirus: 28 more people found positive for Omicron". Cyprus Mail. 17 December 2021. Retrieved 19 December 2021.
  386. ^ @MOH_Kenya (18 December 2021). "Twenty-seven sequences (77%) were confirmed to belong to the newly identified Omicron variant of concern" (Tweet). Retrieved 20 December 2021 – via Twitter.
  387. ^ "В России выявили более 250 случаев заболевания подвидом омикрон-штамма ВA.2". TASS. 2 February 2022. Retrieved 2 February 2022.
  388. ^ a b "COVID-19 Update - 24 December". gov.ky. Retrieved 26 December 2021.
  389. ^ Ministry of Health - Uganda [@@MinofHealthUG] (18 December 2021). "PRESS RELEASE: Update on Omicron Variant in #Uganda" (Tweet). Uganda. Retrieved 19 December 2021 – via Twitter.
  390. ^ "Omicron confirmed in nine African countries, say officials". ABC News. Archived from the original on 7 December 2021. Retrieved 7 December 2021.
  391. ^ Guillén, Beatriz (3 December 2021). "México confirma el primer caso de ómicron en el país" [Mexico confirms the first omicron case in the country]. El País (in Spanish). Mexico. Retrieved 3 December 2021.
  392. ^ "MidCentral hits 90% fully vaccinated milestone; 69 community cases; 62 in hospital; 7 in ICU". Ministry of Health NZ. Retrieved 20 December 2021.
  393. ^ "Namibia detects Omicron coronavirus variant in 18 of 19 samples". Reuters. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 7 December 2021.
  394. ^ "HK reports 7 imported virus cases". Hong Kong's Information Services Department (in Chinese (Hong Kong)). Retrieved 24 December 2021.
  395. ^ "14 imported virus cases found". Hong Kong's Information Services Department (in Chinese (Hong Kong)). Retrieved 30 December 2021.
  396. ^ "Senegal records first Omicron case in tourist who attended demonstration". Reuters. 5 December 2021. Archived from the original on 5 December 2021. Retrieved 5 December 2021.
  397. ^ "Omicron in southern Africa: Mozambique is worried for its economy, especially tourism". Bahrain News Agency. 10 December 2021. Retrieved 10 December 2021.
  398. ^ Newsroom (16 December 2021). "Όμικρον: 17 κρούσματα στην Ελλάδα | Η ΚΑΘΗΜΕΡΙΝΗ". www.kathimerini.gr. Retrieved 20 December 2021.
  399. ^ Bell, Jonathan (21 December 2021). "Omicron cases surge from one to more than 100 in two weeks". www.royalgazette.com. Retrieved 24 December 2021.
  400. ^ Bell, Jonathan (24 December 2021). "Two in hospital as Bermuda passes 6,000 Covid-19 cases". www.royalgazette.com. Retrieved 26 December 2021.
  401. ^ "Latvia gets its first two Omicron cases". Public Broadcasting of Latvia. Reuters. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 6 December 2021.
  402. ^ "Pagājušajā nedēļā par trešdaļu pieaudzis Covid-19 inficēto skaits | Slimību profilakses un kontroles centrs". www.spkc.gov.lv (in Latvian). Retrieved 4 January 2022.
  403. ^ "Comunicate de presa" [Press Releases]. ms.ro (in Romanian). Ministerul Sănătăţii (Health Ministry Romania). 12 December 2021. Retrieved 13 December 2021. So far, 8 cases with the Omicron variant of the SARS-Cov-2 virus have been confirmed in Romania.
  404. ^ "MS: Încă două cazuri de infectare cu varianta Omicron au fost confirmate în România" [Ministry of Health: Two more cases of Omicron infection confirmed in Romania]. digi24.ro (in Romanian). 17 December 2021. Retrieved 18 December 2021. Până în prezent, în România au fost confirmate 13 cazuri cu varianta OMICRON a virusului SARS-Cov-2. [So far, 13 cases of the OMICRON variant of SARS-Cov-2 have been confirmed in Romania.]
  405. ^ "Au fost descoperite încă 9 cazuri de infectare cu varianta Omicron în România" [9 more cases of Omicron infection discovered in Romania]. digi24.ro (in Romanian). 23 December 2021. Retrieved 24 December 2021.
  406. ^ "Covid-19: 245 Omicron cases detected so far, 157 among umrah returnees, says Khairy". The Star. 6 January 2022. Retrieved 6 January 2022.
  407. ^ "Zambia reports more Omicron variant COVID-19 cases". Xinhuanet.com. 11 December 2021. Retrieved 13 December 2021.
  408. ^ Adetifa, Dr Ifedayo (7 December 2021). "Three Additional Cases of Omicron Variant Confirmed". ncdc.gov.ng. Nigeria Centre for Disease Control (NCDC). Retrieved 11 December 2021. In addition to the three cases announced earlier on 1st December 2021, this brings the total number of confirmed cases of the Omicron variant detected in Nigeria to six (6).
  409. ^ "Koronavirus ONLINE: Válek smetl povinné očkování 60+. A 5982 případů za sobotu v ČR". Blesk.cz (in Czech). Archived from the original on 20 December 2021. Retrieved 20 December 2021.
  410. ^ "Kosovo reports first cases of COVID-19 Omicron". Reuters. Pristina. 26 December 2021. Retrieved 28 December 2021. Kosovo's health ministry said on Sunday it had registered its first nine cases of the Omicron coronavirus variant in the Balkan country.
  411. ^ "First cases of the omicron variant of coronavirus confirmed in Slovenia". GOV.SI. 14 December 2021. Retrieved 15 December 2021.
  412. ^ W3bStudio (21 December 2021). "Omicron confirmed in all Slovenian regions but one". Slovenia Times. Retrieved 22 December 2021.{{cite web}}: CS1 maint: numeric names: authors list (link)
  413. ^ "Omicron estimated to represent 40% of all coronavirus cases in Slovenia". Slovenia Times. 30 December 2021. Retrieved 1 January 2022. The National Laboratory of Health, Environment and Food said today it had confirmed 981 omicron cases with PCR tests...
  414. ^ a b "Cases of Omicron variant rise to 8 in Lebanon". news.cn. Retrieved 19 December 2021.
  415. ^ "Lebanon's total Omicron cases rise to 433". ANI News. Xinhua. Retrieved 26 December 2021.
  416. ^ "Covid-19 à La Réunion: identification d'un 2ème cas positif au variant « Omicron »" [Covid-19 in Reunion Island: identification of a 2nd positive case for the "Omicron" variant]. reunion.gouv.fr (in French). Les services de l'État à La Réunion. 3 December 2021. Retrieved 9 December 2021.
  417. ^ a b c d "В России впервые с октября выявили менее 200 тыс. случаев ковида за неделю". ТАСС. Retrieved 20 December 2021.
  418. ^ "Six cases of Omicron variant detected in Turkey – minister". Reuters. 11 December 2021. Retrieved 11 December 2021.
  419. ^ "Laboratorije Odjeljenja za molekularnu dijagnostiku potvrdile 5 slučajeva infekcije Omicron sojem". Institut za javno zdravlje Crne Gore. 16 December 2021. Retrieved 17 December 2021.
  420. ^ "Cambodia confirms 1st case of Omicron COVID-19 variant". Xinhua News Agency. 15 December 2021. Retrieved 15 December 2021.
  421. ^ "Distribución de casos por las VOC delta - ómicron" [Distribution of cases by VOC Delta - Omicron]. National Institute of Health (Peru) [es] (in Spanish). 18 July 2022. Retrieved 31 July 2022.
  422. ^ الأردنية (بترا), وكالة الأنباء. "تسجيل 30 إصابة جديدة بمتحور أوميكرون في المملكة". بترا -وكالة الأنباء الأردنية. Retrieved 5 January 2022.
  423. ^ 畅, 刘 (13 December 2021). "天津从入境人员中检出奥密克戎变异株,为中国内地首次检出" [The Omicron mutant strain was detected in Tianjin from immigrants, which is the first detection in Mainland China]. The Beijing News. Retrieved 13 December 2021.